# Internets
> Global metabolic crisis explained: fructose, liver disease (MASLD), uric acid, and diabetes across populations. Science, clinical tools, and global insights.
Public Ghost content for AI and LLM tooling. This file includes a bounded export of public pages first, then recent public posts.
Append `.md` to any post or page URL to get the content in Markdown (for example, `/example-post.md`).
## Pages
### WWW.INTERNETS.COM
URL: https://www.internets.com/about/
Last updated: 2026-10-12T06:24:28.000Z
Subsection Navigation  

**Book and Sample Chapters:**  
[Buy First Edition](https://www.internets.com/media-buy-the-sweet-killer-first-edition/) • [Ch. 3](https://www.internets.com/media-the-sweet-killer-ch-3-1st-ed/) • [Ch. 5](https://www.internets.com/media-the-sweet-killer-ch-5-1st-ed/) • [Ch. 9](https://www.internets.com/media-the-sweet-killer-ch-9-1st-ed/) • [Ch. 13](https://www.internets.com/media-the-sweet-killer-ch-13-1st-ed/) • [Ch. 16](https://www.internets.com/media-the-sweet-killer-ch-16-1st-ed/) • [Ch. 19](https://www.internets.com/media-the-sweet-killer-ch-19-1st-ed/) • [Ch. 20](https://www.internets.com/media-the-sweet-killer-ch-20-1st-ed/) • [Ch. 21](https://www.internets.com/media-the-sweet-killer-ch-21-1st-ed/)   
**Media and Outreach:**  
[News](https://www.internets.com/media-news/) • [For Journalists](https://www.internets.com/media-press/) • [Videos](https://www.internets.com/media-videos/) • [Social Media](https://www.internets.com/media-social-media/) • [Contact](https://www.internets.com/media-contact-internets/)   
**About:**  
[About Internets](https://www.internets.com/about/) 

## About Internets.com

Internets Press, on the web at WWW.INTERNETS.COM, was founded to confront a growing crisis in the Western Pacific: the rapid rise of obesity, diabetes, fatty liver disease, and metabolic illness driven by high fructose corn syrup in modern foods. 

Within just two generations, the world’s healthiest island populations have become the world’s sickest. Any observer based in the once pristine islands of the Western Pacific can see the singular cause of these illnesses every day by simply going to the main port of every island and seeing container ships unload modern sugar-laden food and drinks.

#### **Our Mission:** Restoring Ancestral Health  

At Internets Press, our mission is simple and urgent:  
To spread evidence-based knowledge about diet, genes, fructose, and ancestral health—and to support community-driven solutions that bring traditional foods back into markets, homes and schools.  
  
We produce clear, accessible content that empowers families, teachers, and policymakers to make informed choices rooted in their own heritage.

#### **What We Do**  

###### **1\. Books, Videos & Public Education**

We create educational materials that explain how toxic doses of fructose exposure in ultra-processed foods fuel today’s metabolic diseases—and how a return to ancestral eating patterns can restore health.  
  
Our publications bring together lived experience across the Pacific and around the world, combining science with storytelling to make complex topics understandable for everyone. 

We publish books. We provide pre-publication versions of our books in several languages and invite comments to constantly upgrade these digital knowledge bases. Subscribe to this service for one year for less than the price of one regular fast food meal and a soda.  
  
**2\. Partnerships With NGOs**

Internets Press works closely with NGOs, local organizations, educational institutions, and community leaders to promote real change on the ground.  

## **Our approach has two key components:**  

######   **A. Education on Ancestral Foods**

Helping ethnic communities rediscover the traditional foods their genes recognize—taro, yam, cassava, breadfruit, ocean proteins, and other staples that protected the health of their ancestors for thousands of generations.  
  
On the island of Saipan, in the past year, increasing knowledge of genes and ancestral foods has created a micro-economics marketplace surge in demand for ancestral ube bread and taro bread.   
  
People who choose to return to the ancestral foods of their grandparents are losing weight, and their biomarkers of fructose toxicity such as uric acid, glucose and HbA1C levels are dropping back towards normal.

######   **B. Supporting Access & Affordability**

Advocating for subsidies that allow ancestral breads (taro bread, ube bread, cassava bread) to be priced to compete with cheap, fructose-laden white bread. 

This is a micro-economics model that can be replicated in all of the islands of the Pacific.  
  
We also support efforts to bring local produce back into schools and marketplaces, strengthening both children’s health and local agriculture. 

## Our Dedication

Internets Press is dedicated to the children of the Pacific and all communities, affected by modern metabolic disease caused by added fructose.   
  
We believe that health can be reclaimed by honoring ancestral knowledge, applying modern science, and restoring the ancient foods on which all humans thrive.  
  
Our commitment is to help every community reconnect with the foods their genes understand—one loaf of bread, one book, one video, and one partnership at a time.

Internets Press is a private health media company based in Saipan, MP USA.

www.internets.com

pgregor@internets.com

Connect with Internets  
[Facebook](https://www.facebook.com/) • [Instagram](https://www.instagram.com/?ref=internets.com) • [YouTube](https://www.youtube.com/?ref=internets.com) • [LinkedIn](https://www.linkedin.com/in/peter-gregor/?ref=internets.com) • [X / Twitter](https://x.com/?ref=internets.com) • [Email](mailto:info@internets.com) 

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-10.25.47---AM.png)
### Metabolic Disease
URL: https://www.internets.com/metabolic-disease/
Last updated: 2026-08-17T09:54:42.000Z
## Disease Pathways and Clinical Concepts

A directory for fatty liver disease, metabolic syndrome, diabetes, cardiovascular risk, uric acid, inflammation, kidney disease, and related systems.

Choose a path

[ 01 Metabolic Syndrome: Criteria for Diagnosis ](https://www.internets.com/metabolic-disease-metabolic-syndrome-definition/) [ 02 Fatty Liver Disease (MASLD) ](https://www.internets.com/metabolic-disease-masld/) [ 03 Type 2 Diabetes ](https://www.internets.com/metabolic-disease-type-2-diabetes/) [ 04 Metabolic Syndrome and Cardiovascular Disease ](https://www.internets.com/metabolic-disease-cardiovascular-disease/) [ 05 Uric Acid: The Early Warning Signal ](https://www.internets.com/metabolic-disease-uric-acid/) [ 06 Inflammation and Metabolic Disease ](https://www.internets.com/metabolic-disease-inflammation/) 

Complete directory

Overview5 links 
- [Metabolic Disease](https://www.internets.com/metabolic-disease/)
- [Can Metabolic Syndrome Be Reversed?](https://www.internets.com/metabolic-disease-reversal/)
- [Dyslipidemia](https://www.internets.com/metabolic-disease-dyslipidemia/)
- [The Fructose Disease Arc](https://www.internets.com/metabolic-disease-fructose-disease-arc/)
- [The Warburg Effect](https://www.internets.com/metabolic-disease-fructose-warburg-effect/)
Fatty liver and liver metabolism6 links 
- [Fatty Liver Disease (MASLD)](https://www.internets.com/metabolic-disease-masld/)
- [Is Fatty Liver Reversible?](https://www.internets.com/is-fatty-liver-reversible/)
- [MASLD Explained Simply](https://www.internets.com/metabolic-disease-masld-explained/)
- [The Cardio-Hepatic Axis](https://www.internets.com/metabolic-disease-cardio-hepatic-axis/)
- [What Causes Fatty Liver If You Don't Drink?](https://www.internets.com/what-causes-fatty-liver-if-you-dont-drink/)
- [What Is Fatty Liver Disease - MASLD?](https://www.internets.com/what-is-fatty-liver-disease-masld/)
Insulin resistance and metabolic syndrome11 links 
- [Diabetes and Cancer](https://www.internets.com/diabetes-and-cancer/)
- [Metabolic Syndrome Biochemistry](https://www.internets.com/metabolic-disease-metabolic-syndrome-biochemistry/)
- [Metabolic Syndrome Clinical Aspects](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)
- [Metabolic Syndrome: Criteria for Diagnosis](https://www.internets.com/metabolic-disease-metabolic-syndrome-definition/)
- [Obesity](https://www.internets.com/metabolic-disease-obesity/)
- [Prediabetes](https://www.internets.com/metabolic-disease-prediabetes/)
- [Type 2 Diabetes](https://www.internets.com/metabolic-disease-type-2-diabetes/)
- [Visceral Adiposity and Inflammatory Signaling](https://www.internets.com/metabolic-disease-visceral-adiposity-and-inflammatory-signaling/)
- [What Is Metabolic Syndrome?](https://www.internets.com/what-is-metabolic-syndrome/)
- [Why Some Populations Develop Diabetes at Lower Body Weight](https://www.internets.com/why-some-populations-develop-diabetes-at-lower-body-weight/)
- [Why Some Populations Get Diabetes at Lower BMI](https://www.internets.com/diabetes-risk-lower-bmi-ancestry/)
Cardiovascular risk8 links 
- [HDL Cholesterol](https://www.internets.com/metabolic-disease-hdl-cholesterol/)
- [HFpEF](https://www.internets.com/metabolic-disease-hfpef/)
- [Hypertension](https://www.internets.com/metabolic-disease-hypertension/)
- [Metabolic Syndrome and Cardiovascular Disease](https://www.internets.com/metabolic-disease-cardiovascular-disease/)
- [Small Dense LDL and Atherosclerosis](https://www.internets.com/metabolic-disease-small-dense-ldl/)
- [Triglycerides and Cardiovascular Risk](https://www.internets.com/metabolic-disease-triglycerides-cardiovascular-risk/)
- [What Causes High Triglycerides?](https://www.internets.com/what-causes-high-triglycerides/)
- [What Is Cholesterol?](https://www.internets.com/metabolic-disease-what-is-cholesterol/)
Uric acid, kidney, and blood pressure6 links 
- [Hyperuricemia, High Uric Acid](https://www.internets.com/metabolic-disease-hyperuricemia/)
- [Renal Failure](https://www.internets.com/metabolic-disease-renal-failure/)
- [The Renin-Angiotensin Aldosterone System (RAAS)](https://www.internets.com/renin/)
- [Uric Acid: The Early Warning Signal](https://www.internets.com/metabolic-disease-uric-acid/)
- [What Causes High Uric Acid?](https://www.internets.com/what-causes-high-uric-acid/)
- [Why Uric Acid Is No Longer Just a Gout Story](https://www.internets.com/why-uric-acid-is-no-longer-just-a-gout-story/)
Related disease systems6 links 
- [Dementia](https://www.internets.com/metabolic-disease-dementia/)
- [Inflammation and Metabolic Disease](https://www.internets.com/metabolic-disease-inflammation/)
- [Interleukin-6 (IL-6)](https://www.internets.com/metabolic-disease-interleukin-6/)
- [Sleep Apnea](https://www.internets.com/metabolic-disease-sleep-apnea/)
- [The Gut Microbiome and Metabolism](https://www.internets.com/metabolic-disease-gut-microbiome-metabolism/)
- [Tumor Necrosis Factor](https://www.internets.com/metabolic-disease-tnf/)

## Patient Explainers

Plain-language entry points for readers trying to recognize early metabolic disease and inherited risk.

[How Do I Know I May Have Insulin Resistance?](https://www.internets.com/insulin-resistance-symptoms/) [Prediabetes Symptoms: Early Signs of Metabolic Disease](https://www.internets.com/prediabetes-symptoms-early-signs-of-metabolic-disease/) [Ancestry, Geography, and Diabetes Risk](https://www.internets.com/ancestry-geography-and-diabetes-risk/) 

## 2026 Evidence Update

**Summary:** The metabolic disease section should now explicitly connect liver, adipose tissue, pancreas, cardiovascular risk, and kidney risk. The 2026 AHA/ACC/ADA/ASN cardiovascular-kidney-metabolic guideline formalizes this integrated view through CKM syndrome: metabolic risk factors such as obesity and type 2 diabetes intersect with chronic kidney disease and cardiovascular disease rather than sitting in separate silos.

This matters for Internets because fructose biology, fatty liver, hyperuricemia, triglycerides, hypertension, kidney disease, and cardiovascular disease are often different surfaces of the same underlying metabolic network. The newer guideline framing supports the site’s section architecture: readers should be able to move from insulin resistance and MASLD to dyslipidemia, hypertension, CKD, HFpEF, and cardiovascular disease without treating each page as a disconnected topic.

**Sources:** 2026 AHA/ACC/ADA/ASN CKM guideline summary, [JACC Guideline-at-a-Glance](https://www.jacc.org/doi/10.1016/j.jacc.2026.05.008?ref=internets.com); American Heart Association, [CKM guideline news release](https://newsroom.heart.org/news/first-ever-guideline-on-cardiovascular-kidney-metabolic-syndrome-issued?ref=internets.com).

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/07/Screenshot-2026-07-05-at-4.19.33---PM.png)

## Related Framework

For the current integrated guideline framework connecting metabolic disease with kidney and cardiovascular risk, see [Cardiovascular-Kidney-Metabolic Syndrome](https://www.internets.com/metabolic-disease-cardiovascular-kidney-metabolic-syndrome/).

## New Clinical Marker Pages

For deeper clinical orientation, see [MASLD screening with FIB-4 and liver stiffness](https://www.internets.com/metabolic-disease-masld-screening-fib-4-liver-stiffness/), [albuminuria and eGFR for kidney risk](https://www.internets.com/metabolic-disease-albuminuria-egfr-kidney-risk/), and [ApoB and non-HDL cholesterol for atherogenic dyslipidemia](https://www.internets.com/metabolic-disease-apob-non-hdl-cholesterol-atherogenic-dyslipidemia/).

## Related Treatment Pages

For current therapy context, see [GLP-1 and GIP therapy](https://www.internets.com/metabolic-disease-glp-1-gip-therapy-semaglutide-tirzepatide/), [SGLT2 inhibitors for kidney and heart protection](https://www.internets.com/metabolic-disease-sglt2-inhibitors-kidney-heart-protection/), and [MASH treatment with resmetirom and metabolic care](https://www.internets.com/metabolic-disease-mash-resmetirom-treatment/).
### (Untitled)
URL: https://www.internets.com/internets-com/
Last updated: 2026-08-03T14:35:02.000Z
DNA. Diet. Destiny.

# Fructose, genes, and the modern metabolic crisis

Internets is a global health knowledge platform focused on fructose metabolism, fatty liver disease, uric acid, insulin resistance, diabetes, and the population-wide crisis of modern metabolic disease. 

[Explore the Science](https://www.internets.com/fructose-science/) [Read About The Sweet Killer](https://www.internets.com/media-the-sweet-killer/) 

## Core Topics

A practical guide to the science, disease patterns, clinical implications, and public-health consequences of the metabolic pandemic. 

Fructose metabolism

Fatty liver disease

Uric acid and insulin resistance

Diabetes and metabolic syndrome

Global population health

Start Here

## Choose a pathway

Browse Internets by topic: science, disease, food, clinical resources, media, and the global health implications of metabolic disease. 

[ 01 Global Crisis Explore the worldwide metabolic-health emergency and its population-level consequences. ](https://www.internets.com/global-metabolic-crisis/) [ 02 Metabolic Disease Understand obesity, fatty liver, insulin resistance, diabetes, and related disease pathways. ](https://www.internets.com/metabolic-disease/) [ 03 Fructose Science Follow the biological mechanisms linking fructose, uric acid, liver fat, and metabolic disruption. ](https://www.internets.com/fructose-science/) [ 04 Clinical Resources Find resources for clinicians, health professionals, and evidence-focused readers. ](https://www.internets.com/clinical-resources/) [ 05 Food Review dietary drivers, food systems, and practical nutrition-related metabolic risks. ](https://www.internets.com/food/) [ 06 Media Access news, press materials, videos, sample chapters, and contact information. ](https://www.internets.com/media/) 

![The Sweet Killer book cover](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-24-at-12.16.07---PM-1.png) 

Featured Book

## The Sweet Killer

**Fructose, Genes and a Metabolic Pandemic** connects molecular biology, diet, inherited susceptibility, and global health into one urgent public-health narrative. 

[Book Hub](https://www.internets.com/media-the-sweet-killer/) [Buy First Edition](https://www.internets.com/media-buy-the-sweet-killer-first-edition/) [Sample Chapters](https://www.internets.com/media-the-sweet-killer-ch-3-1st-ed/) 

Rotary International and American College of Cardiology members can view the purchase page for the special purchase-related foundation instructions. 

Audiences

## Built for readers, clinicians, journalists, and communities

### For clinicians and health professionals

Use Internets as a reference point for the metabolic connections among fructose, liver fat, uric acid, insulin resistance, diabetes, and cardiometabolic disease. 

[Clinical Resources →](https://www.internets.com/clinical-resources/) 

### For media and public-health outreach

Find press resources, background pages, sample chapters, videos, and contact links for coverage of metabolic disease and The Sweet Killer. 

[Media Center →](https://www.internets.com/media/) 

## Follow the science of the metabolic pandemic

Explore the major sections of Internets, read sample chapters from The Sweet Killer, or contact Internets Press for media and outreach. 

[Contact Internets](https://www.internets.com/media-contact-internets/) [About Internets](https://www.internets.com/about/)
### Metabolic Syndrome Biochemistry
URL: https://www.internets.com/metabolic-disease-metabolic-syndrome-biochemistry/
Last updated: 2026-08-17T08:55:29.000Z
Subsection Navigation 

Core Pages: [Fructose Disease Arc](https://www.internets.com/metabolic-disease-fructose-disease-arc/) • [Metabolic Disease](https://www.internets.com/metabolic-disease/) • [Metabolic Syndrome (Biochemistry)](https://www.internets.com/metabolic-disease-metabolic-syndrome-biochemistry/) • [Metabolic Syndrome (Clinical)](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)  | Body Fat and Metabolic Drivers: [Visceral Adiposity & Inflammatory Signaling](https://www.internets.com/metabolic-disease-visceral-adiposity-and-inflammatory-signaling/) • [Cardio-Hepatic Axis](https://www.internets.com/metabolic-disease-cardio-hepatic-axis/) • [Inflammation](https://www.internets.com/metabolic-disease-inflammation/)  | Lipid and Metabolic Risk: [Cholesterol](https://www.internets.com/metabolic-disease-what-is-cholesterol/) • [Triglycerides](https://www.internets.com/metabolic-disease-triglycerides-cardiovascular-risk/) • [LDL](https://www.internets.com/metabolic-disease-small-dense-ldl/) • [HDL](https://www.internets.com/metabolic-disease-hdl-cholesterol/)  | Clinical Disease Expression: [Dyslipidemia](https://www.internets.com/metabolic-disease-dyslipidemia/) • [Obesity](https://www.internets.com/metabolic-disease-obesity/) • [Fatty Liver](https://www.internets.com/metabolic-disease-masld/) • [Prediabetes](https://www.internets.com/metabolic-disease-prediabetes/) • [Type 2 Diabetes](https://www.internets.com/metabolic-disease-type-2-diabetes/) • [Hypertension](https://www.internets.com/metabolic-disease-hypertension/) • [Cardiovascular Disease](https://www.internets.com/metabolic-disease-cardiovascular-disease/) • [Sleep Apnea](https://www.internets.com/metabolic-disease-sleep-apnea/) • [HFpEF](https://www.internets.com/metabolic-disease-hfpef/) • [Hyperuricemia](https://www.internets.com/metabolic-disease-hyperuricemia/) • [Renal Failure](https://www.internets.com/metabolic-disease-renal-failure/) • [Gut Microbiome](https://www.internets.com/metabolic-disease-gut-microbiome-metabolism/) • [Renin-Angiotensin System](https://www.internets.com/renin/)  | Special Topics: [Dementia](https://www.internets.com/metabolic-disease-dementia/) • [Fructose & Cancer Metabolism](https://www.internets.com/fructose-science-fructose-cancer-metabolism/) • [Warburg Effect](https://www.internets.com/metabolic-disease-fructose-warburg-effect/)  | Reversal and Recovery: [Reversal with Diet](https://www.internets.com/metabolic-disease-reversal/) • [Reversal with Drugs](https://www.internets.com/clinical-resources-reversal-with-drugs-md/) 

## Introduction

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/05/Screenshot-2026-05-09-at-9.40.11---PM-1.png)

Metabolic syndrome is not a single disease. It is a pattern of biochemical overload affecting multiple organs that regulate energy, glucose, and lipid metabolism.

What appears clinically as obesity, elevated glucose, fatty liver, and abnormal lipids reflects a deeper internal process: chronic exposure to excess nutrient substrate.

---

## Metabolic flexibility—and its loss

Normal metabolism is flexible.

The body can switch between:

- storing energy after meals
- mobilizing energy during fasting

This balance depends on coordinated signaling between liver, muscle, adipose tissue, and pancreas.

Metabolic syndrome begins when that flexibility is lost.

---

## Metabolic overload

The central driver is metabolic overload.

When nutrient intake repeatedly exceeds the body’s capacity to process it:

- excess substrate accumulates
- storage pathways become saturated
- regulatory signaling begins to fail

Key early changes include:

- visceral fat expansion
- increased fatty acid flux to the liver
- rising triglyceride production
- early insulin resistance

This is not a single event—it is a sustained biochemical state.

---

## The liver: central processing failure

The liver is the primary metabolic hub.

It receives nutrients directly from the intestine and regulates:

- glucose output
- lipid synthesis
- triglyceride export

Under chronic overload:

- fat accumulates in hepatocytes
- de novo lipogenesis increases
- VLDL production rises
- hepatic insulin signaling deteriorates

Fatty liver (MASLD) is often the first visible sign of this process.

---

## De novo lipogenesis

Excess carbohydrate—especially fructose—is converted to fat in the liver.

This pathway is upregulated in metabolic syndrome:

- glucose and fructose enter hepatocytes
- acetyl-CoA is diverted into fatty acid synthesis
- triglycerides accumulate
- fat is exported as VLDL

This links dietary sugar directly to fatty liver and elevated triglycerides.

---

## Visceral adipose tissue

Visceral fat is metabolically active.

As it expands, it releases:

- free fatty acids
- inflammatory cytokines
- adipokine signals that impair insulin action

This creates a feedback loop:

visceral fat expansion  
→ inflammatory signaling  
→ worsening insulin resistance  
→ increased hepatic fat

Central obesity is therefore a biochemical driver, not just a marker.

---

## Insulin resistance

Insulin resistance affects multiple tissues simultaneously.

- muscle takes up less glucose
- liver continues producing glucose
- pancreas increases insulin output

This leads to:

- hyperinsulinemia
- rising fasting glucose
- eventual pancreatic strain

Insulin resistance is both a consequence and amplifier of metabolic overload.

---

## Triglycerides and lipid dysfunction

Metabolic syndrome produces a characteristic lipid pattern:

- elevated triglycerides
- reduced HDL cholesterol
- small, dense LDL particles

This reflects:

- hepatic overproduction of triglyceride-rich lipoproteins
- impaired lipid clearance
- altered lipoprotein remodeling

This pattern is strongly associated with cardiovascular risk.

---

## Inflammation and vascular effects

Chronic metabolic overload produces low-grade inflammation.

This affects:

- adipose tissue
- liver
- vascular endothelium

Over time, this contributes to:

- endothelial dysfunction
- impaired vascular signaling
- atherosclerotic progression

Metabolic syndrome is therefore both a metabolic and vascular condition.

---

## Why these abnormalities cluster

The defining feature of metabolic syndrome is clustering.

This occurs because the same underlying processes affect multiple organs:

- liver fat accumulation
- visceral adipose signaling
- insulin resistance
- triglyceride overproduction
- inflammatory activation

These are not separate diseases—they are interconnected expressions of the same biochemical state.

---

## The modern food environment

Modern diets continuously drive these pathways.

Refined carbohydrates, added sugars, and ultra-processed foods:

- deliver rapid substrate
- lack fiber and satiety
- are consumed frequently throughout the day

This produces sustained metabolic pressure on the liver, pancreas, and adipose tissue.

---

## Bottom line

Metabolic syndrome is the biochemical consequence of chronic overload of added sugars in the modern diet.

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-13-at-10.19.02---AM.png)

At its core are:

- excess nutrient exposure
- hepatic fat accumulation
- de novo lipogenesis
- visceral adipose signaling
- insulin resistance
- triglyceride overproduction
- low-grade inflammation

These processes interact across organs and over time, producing the clinical pattern recognized as metabolic syndrome.

**Where to Go Next**

Readers interested in exploring these topics further may wish to continue with the following sections:

• Fructose Metabolism

• Metabolic Syndrome

• Fatty Liver Disease (MASLD)

• Gene–Diet Interaction

Each of these topics examines a different aspect of the metabolic processes discussed in this overview.

## Related Metabolic Disease Pages

For the clinical diagnostic framework, see [Metabolic Syndrome Criteria](https://www.internets.com/metabolic-disease-metabolic-syndrome-definition/). For the patient-facing liver explanation, see [MASLD Explained Simply](https://www.internets.com/metabolic-disease-masld-explained/).
### Fructose Metabolism
URL: https://www.internets.com/fructose-science-fructose-metabolism/
Last updated: 2026-08-17T08:55:05.000Z
Library guide

## Explore Fructose Metabolism in the fructose mechanism map.

Move from this topic into the core pathways: metabolism, liver biology, uric acid, and insulin resistance.

[ Metabolic Science Return to the science hub. ](https://www.internets.com/fructose-science/) [ Ketohexokinase The enzyme that begins the cascade. ](https://www.internets.com/fructose-science-khk/) [ Uric Acid A downstream signal of ATP stress. ](https://www.internets.com/fructose-science-uric-acid-biochemistry/) 

**Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-1.07.03---PM.png)

Fructose is a naturally occurring sugar found in fruit, honey, and certain vegetables. In modern diets, however, fructose is frequently consumed in much larger quantities through added sugars such as sucrose and high-fructose corn syrup.

These sugars are widely used in beverages, desserts, processed foods, and sweetened products.

Although fructose and glucose share the same chemical formula, their metabolic pathways differ in important ways.

Understanding how fructose is processed in the body helps explain why researchers have become increasingly interested in its role in metabolic health.

**Absorption in the Intestine**

After ingestion, fructose is absorbed in the small intestine through specialized transport proteins located in intestinal cells.

The primary transporter responsible for fructose uptake is GLUT5, which facilitates the movement of fructose molecules from the intestinal lumen into enterocytes.

From there, fructose enters the portal circulation, the vascular system that carries nutrients directly from the intestine to the liver.

Because of this pathway, the liver receives much of the fructose consumed in the diet shortly after ingestion.

**The Liver as the Primary Site of Fructose Metabolism**

Once fructose reaches the liver, it is rapidly metabolized.

The first major step is catalyzed by the enzyme ketohexokinase (KHK), which phosphorylates fructose to form fructose-1-phosphate. This reaction uses cellular ATP and occurs quickly compared with the early steps of glucose metabolism.

Because this pathway bypasses some of the regulatory checkpoints present in glucose metabolism, large amounts of fructose can be processed rapidly by liver cells.

Downstream metabolic intermediates may then enter pathways involved in energy production or lipid synthesis.

**ATP Depletion and Uric Acid**

Rapid phosphorylation of fructose can temporarily reduce intracellular ATP levels within hepatocytes.

When ATP levels decline, the breakdown of adenine nucleotides may increase, producing uric acid as a metabolic by-product.

Researchers have proposed that this process may contribute to oxidative stress, inflammation, and other metabolic changes under conditions of high fructose exposure.

The role of uric acid in metabolic disease remains an area of active investigation.

**Fructose and Lipid Synthesis**

Another important consequence of fructose metabolism is its potential contribution to de novo lipogenesis, the synthesis of fatty acids within the liver.

When excess carbohydrate substrates are available, the liver may convert these molecules into triglycerides. These triglycerides can accumulate within liver cells or be exported into the bloodstream as very-low-density lipoproteins (VLDL).

Elevated triglyceride levels and liver fat accumulation are frequently observed in individuals with metabolic syndrome and fatty liver disease.

**Fructose in the Modern Diet**

Historically, humans consumed fructose primarily through whole foods such as fruit. In those contexts, fructose intake was typically modest and accompanied by fiber, water, and other nutrients that slowed absorption.

Modern food systems, however, often deliver fructose in concentrated forms through sweetened beverages and processed foods.

This change in exposure patterns has prompted researchers to investigate whether large and frequent doses of fructose may influence metabolic pathways in ways that differ from traditional dietary contexts.

**Ongoing Research**

The relationship between fructose and metabolic disease remains an active area of scientific study.

Some researchers emphasize the role of overall caloric excess, while others focus on specific metabolic pathways influenced by fructose metabolism.

Internets.com presents these topics with the goal of clarifying the biological mechanisms involved and summarizing the evolving scientific discussion.

**Next Topics**

Readers interested in the biochemical details of this pathway may explore:

**• GLUT5 Transport**

**• Ketohexokinase (KHK) Pathway**

**• ATP Depletion and Uric Acid**

**• Fructose and Fatty Liver Disease**

These pages examine the individual components of fructose metabolism in greater depth.

 Recent Evidence: Fructose Metabolism, Gut, Liver, and Disease

**Summary:** Recent reviews continue to support the core idea that fructose is metabolically distinct from glucose, especially when consumed as added sugar outside a whole-food matrix. The key scientific point is simple: fructose metabolism links the intestine, liver, uric acid pathway, triglyceride production, gut microbiota, and metabolic disease risk.

A 2025 review by **Zhenhong Li and colleagues** describes fructose absorption, distribution, and metabolism, then connects fructose metabolism with metabolic disease, hyperinsulinemia, hyperuricemia, inflammation, and cancer biology. This does not mean every fructose exposure has the same effect; dose, food context, duration, and background metabolic risk all matter.

A 2026 review by **Marielle Cheikh and Fernando Forato Anhê** adds a gut-liver perspective. Their review emphasizes that industrially processed fructose can reach intestinal regions and microbial communities that would be less exposed under traditional whole-food dietary patterns. That makes the intestine and microbiome part of the fructose story, not merely a passive route to the liver.

**Why this matters:** fructose metabolism is best understood as a connected network: intestinal transport, hepatic phosphorylation, ATP stress, uric acid generation, de novo lipogenesis, triglyceride export, microbiome effects, and insulin resistance can reinforce one another in susceptible people.

**Sources:** Li Z. et al., *Molecular Biomedicine*, 2025, PMID [40549205](https://pubmed.ncbi.nlm.nih.gov/40549205/?ref=internets.com); Cheikh M. and Anhê F.F., *Biochemical Journal*, 2026, PMID [42233430](https://pubmed.ncbi.nlm.nih.gov/42233430/?ref=internets.com).

## Related Fructose Science Pages

For the broader disease pathway, see [The Biology of Metabolic Disease](https://www.internets.com/fructose-science-biology-of-metabolic-disease/). For the intestinal-to-liver route that carries absorbed fructose, see [The Portal Circulation](https://www.internets.com/fructose-science-portal-vein/).
### Metabolic Syndrome Clinical Aspects
URL: https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/
Last updated: 2026-08-17T08:55:23.000Z
Subsection Navigation 

Core Pages: [Fructose Disease Arc](https://www.internets.com/metabolic-disease-fructose-disease-arc/) • [Metabolic Disease](https://www.internets.com/metabolic-disease/) • [Metabolic Syndrome (Biochemistry)](https://www.internets.com/metabolic-disease-metabolic-syndrome-biochemistry/) • [Metabolic Syndrome (Clinical)](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)  | Body Fat and Metabolic Drivers: [Visceral Adiposity & Inflammatory Signaling](https://www.internets.com/metabolic-disease-visceral-adiposity-and-inflammatory-signaling/) • [Cardio-Hepatic Axis](https://www.internets.com/metabolic-disease-cardio-hepatic-axis/) • [Inflammation](https://www.internets.com/metabolic-disease-inflammation/)  | Lipid and Metabolic Risk: [Cholesterol](https://www.internets.com/metabolic-disease-what-is-cholesterol/) • [Triglycerides](https://www.internets.com/metabolic-disease-triglycerides-cardiovascular-risk/) • [LDL](https://www.internets.com/metabolic-disease-small-dense-ldl/) • [HDL](https://www.internets.com/metabolic-disease-hdl-cholesterol/)  | Clinical Disease Expression: [Dyslipidemia](https://www.internets.com/metabolic-disease-dyslipidemia/) • [Obesity](https://www.internets.com/metabolic-disease-obesity/) • [Fatty Liver](https://www.internets.com/metabolic-disease-masld/) • [Prediabetes](https://www.internets.com/metabolic-disease-prediabetes/) • [Type 2 Diabetes](https://www.internets.com/metabolic-disease-type-2-diabetes/) • [Hypertension](https://www.internets.com/metabolic-disease-hypertension/) • [Cardiovascular Disease](https://www.internets.com/metabolic-disease-cardiovascular-disease/) • [Sleep Apnea](https://www.internets.com/metabolic-disease-sleep-apnea/) • [HFpEF](https://www.internets.com/metabolic-disease-hfpef/) • [Hyperuricemia](https://www.internets.com/metabolic-disease-hyperuricemia/) • [Renal Failure](https://www.internets.com/metabolic-disease-renal-failure/) • [Gut Microbiome](https://www.internets.com/metabolic-disease-gut-microbiome-metabolism/) • [Renin-Angiotensin System](https://www.internets.com/renin/)  | Special Topics: [Dementia](https://www.internets.com/metabolic-disease-dementia/) • [Fructose & Cancer Metabolism](https://www.internets.com/fructose-science-fructose-cancer-metabolism/) • [Warburg Effect](https://www.internets.com/metabolic-disease-fructose-warburg-effect/)  | Reversal and Recovery: [Reversal with Diet](https://www.internets.com/metabolic-disease-reversal/) • [Reversal with Drugs](https://www.internets.com/clinical-resources-reversal-with-drugs-md/) 

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-13-at-9.49.28---AM.png)

Unknown as a diagnosis prior to 1998, metabolic syndrome is a clinical term used to describe a cluster of metabolic abnormalities that tend to appear together in the same individual. These abnormalities typically include abdominal obesity, elevated triglycerides, reduced HDL cholesterol, high blood pressure, and impaired glucose regulation.

When several of these features occur simultaneously, the risk of cardiovascular disease and type 2 diabetes increases substantially.

Although metabolic syndrome is defined by specific diagnostic criteria, it is best understood not as a single disease but as a pattern of metabolic dysfunction involving multiple organ systems.

## **Diagnostic Features**

Different medical organizations use slightly different definitions, but metabolic syndrome generally involves the presence of several of the following factors:

• increased waist circumference or abdominal obesity

• elevated triglyceride levels

• reduced HDL cholesterol

• elevated blood pressure

• elevated fasting glucose or insulin resistance

The presence of three or more of these features typically meets the clinical definition of metabolic syndrome.

These diagnostic criteria are designed to identify individuals who may be at increased risk for future cardiometabolic disease.

## **Insulin Resistance**

One of the central biological processes associated with metabolic syndrome is insulin resistance.

Insulin is a hormone produced by the pancreas that allows cells to absorb glucose from the bloodstream. When tissues become less responsive to insulin, the body compensates by producing higher levels of the hormone.

Over time, this compensatory response may fail to maintain normal glucose regulation. Blood sugar levels may gradually rise, eventually progressing to prediabetes or type 2 diabetes.

Insulin resistance is closely linked with visceral adiposity, liver fat accumulation, and chronic metabolic stress.

## **Visceral Fat and Adipose Signaling**

Body fat distribution plays an important role in metabolic health. Fat stored deep within the abdomen — known as visceral adipose tissue — appears to have particularly strong metabolic effects.

Visceral fat releases free fatty acids and signaling molecules that influence inflammation, lipid metabolism, and insulin sensitivity. When visceral adiposity increases, these signals can contribute to metabolic dysfunction in the liver, pancreas, and vascular system.

This process helps explain why abdominal obesity is strongly associated with metabolic syndrome.

## **The Role of the Liver**

The liver occupies a central position in the metabolic processes associated with metabolic syndrome.

When excess energy is delivered to the liver, triglycerides may accumulate within liver cells, leading to metabolic dysfunction–associated steatotic liver disease (MASLD). Liver fat accumulation can disrupt normal glucose and lipid metabolism, contributing to insulin resistance and dyslipidemia.

Elevated liver fat is therefore often viewed as an early indicator of metabolic stress.

## **Environmental and Lifestyle Factors**

Several environmental factors contribute to the development of metabolic syndrome:

• diets high in refined carbohydrates and added sugars, such as high fructose corn syrup

• sedentary lifestyle

• excess caloric intake

• chronic stress and disrupted sleep

• genetic susceptibility with some ethnicities having more fatty liver, others more elevated uric acid, others more heart attacks

These influences interact with biological systems that regulate energy balance, lipid metabolism, and hormonal signaling.

Understanding how environmental exposures interact with metabolic physiology is essential for explaining why metabolic syndrome has become increasingly common.

## **Cardiovascular Risk**

In the United States, while the main focus has been on lipids research and USADA dietary guidelines (until 2026) have **not** emphasized the dangers of sugar, metabolic syndrome has not seen the appropriate intensity of research, compared to the overwhelming evidence in the international literature to the dangers of added sugars in the American diet. 

The incidence of heart failure with preserved ejection fraction (HFpEF) in increasing. The focus of treatment of HFpEF is to treat the co-morbidities. These co-morbidities usually can be summed up in one diagnosis, "metabolic syndrome".

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-13-at-10.00.11---AM.png)

Individuals with metabolic syndrome face an increased risk of cardiovascular disease. Elevated triglycerides, reduced HDL cholesterol, hypertension, and chronic inflammation all contribute to vascular injury over time.

These metabolic disturbances can accelerate the development of atherosclerosis, the process by which fatty deposits accumulate within arterial walls.

Because cardiovascular disease remains one of the leading causes of death worldwide, identifying metabolic syndrome early can be important for preventive care. 

## **Prevention and Management**

Management of metabolic syndrome typically focuses on reducing the underlying metabolic stress contributing to these conditions.

Common strategies include:

• improving diet quality

• increasing physical activity

• reducing visceral adiposity

• managing blood pressure and lipid levels

• treating insulin resistance and glucose abnormalities

Because metabolic syndrome involves multiple interacting systems, treatment often requires a comprehensive approach rather than a single intervention.

## **Related Topics**

Readers interested in the biological mechanisms underlying metabolic syndrome may also explore:

**•** [**Overview of Metabolic Disease**](https://www.internets.com/metabolic-disease)

**•** [**History of Sugar before 1984**](https://www.internets.com/food-history-of-sugar-pre-1984/)

**•** [**History of Sugar after 1984**](https://www.internets.com/food-history-of-sugar-after-1984/)

**•** [**Cardiovascular Disease**](https://www.internets.com/metabolic-disease-cardiovascular-disease/)

These topics examine the metabolic pathways and some of the history of sugars that contribute to the development of metabolic syndrome.

## Related Metabolic Disease Pages

For the formal diagnostic thresholds, see [Metabolic Syndrome Criteria](https://www.internets.com/metabolic-disease-metabolic-syndrome-definition/). For the liver-focused companion page, see [MASLD Explained Simply](https://www.internets.com/metabolic-disease-masld-explained/).
### Fatty Liver Disease (MASLD)
URL: https://www.internets.com/metabolic-disease-masld/
Last updated: 2026-08-17T09:55:58.000Z
Subsection Navigation 

Core Pages: [Fructose Disease Arc](https://www.internets.com/metabolic-disease-fructose-disease-arc/) • [Metabolic Disease](https://www.internets.com/metabolic-disease/) • [Metabolic Syndrome (Biochemistry)](https://www.internets.com/metabolic-disease-metabolic-syndrome-biochemistry/) • [Metabolic Syndrome (Clinical)](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)  | Body Fat and Metabolic Drivers: [Visceral Adiposity & Inflammatory Signaling](https://www.internets.com/metabolic-disease-visceral-adiposity-and-inflammatory-signaling/) • [Cardio-Hepatic Axis](https://www.internets.com/metabolic-disease-cardio-hepatic-axis/) • [Inflammation](https://www.internets.com/metabolic-disease-inflammation/)  | Lipid and Metabolic Risk: [Cholesterol](https://www.internets.com/metabolic-disease-what-is-cholesterol/) • [Triglycerides](https://www.internets.com/metabolic-disease-triglycerides-cardiovascular-risk/) • [LDL](https://www.internets.com/metabolic-disease-small-dense-ldl/) • [HDL](https://www.internets.com/metabolic-disease-hdl-cholesterol/)  | Clinical Disease Expression: [Dyslipidemia](https://www.internets.com/metabolic-disease-dyslipidemia/) • [Obesity](https://www.internets.com/metabolic-disease-obesity/) • [Fatty Liver](https://www.internets.com/metabolic-disease-masld/) • [Prediabetes](https://www.internets.com/metabolic-disease-prediabetes/) • [Type 2 Diabetes](https://www.internets.com/metabolic-disease-type-2-diabetes/) • [Hypertension](https://www.internets.com/metabolic-disease-hypertension/) • [Cardiovascular Disease](https://www.internets.com/metabolic-disease-cardiovascular-disease/) • [Sleep Apnea](https://www.internets.com/metabolic-disease-sleep-apnea/) • [HFpEF](https://www.internets.com/metabolic-disease-hfpef/) • [Hyperuricemia](https://www.internets.com/metabolic-disease-hyperuricemia/) • [Renal Failure](https://www.internets.com/metabolic-disease-renal-failure/) • [Gut Microbiome](https://www.internets.com/metabolic-disease-gut-microbiome-metabolism/) • [Renin-Angiotensin System](https://www.internets.com/renin/)  | Special Topics: [Dementia](https://www.internets.com/metabolic-disease-dementia/) • [Fructose & Cancer Metabolism](https://www.internets.com/fructose-science-fructose-cancer-metabolism/) • [Warburg Effect](https://www.internets.com/metabolic-disease-fructose-warburg-effect/)  | Reversal and Recovery: [Reversal with Diet](https://www.internets.com/metabolic-disease-reversal/) • [Reversal with Drugs](https://www.internets.com/clinical-resources-reversal-with-drugs-md/) 

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-9.59.41---AM.png)

Metabolic dysfunction–associated steatotic liver disease (MASLD) is one of the most common liver disorders worldwide. The condition occurs when excess fat accumulates within liver cells in individuals who have metabolic risk factors such as obesity, insulin resistance, dyslipidemia, or type 2 diabetes.

In many cases MASLD develops silently, producing few symptoms during its early stages. It is often discovered incidentally during imaging studies or routine laboratory testing.

Despite its subtle onset, fatty liver disease has important implications for metabolic health and is increasingly recognized as a key indicator of systemic metabolic dysfunction.

**What Is Liver Fat?**

The liver normally contains small amounts of fat as part of its metabolic activity. However, when triglycerides accumulate beyond normal levels within liver cells, this condition is referred to as hepatic steatosis, or fatty liver.

This accumulation occurs when the balance between lipid production, lipid oxidation, and lipid export becomes disrupted.

Several metabolic pathways contribute to this process:

• increased delivery of fatty acids from adipose tissue

• increased synthesis of fatty acids within the liver

• reduced oxidation of fatty acids

• impaired export of triglycerides from the liver

When these processes favor fat accumulation, liver steatosis may develop.

**The Liver and Energy Metabolism**

The liver plays a central role in managing nutrients absorbed from the intestine. After a meal, carbohydrates, fats, and proteins enter the portal circulation and are delivered directly to the liver.

The liver then determines how these nutrients are processed, stored, or distributed throughout the body.

Under conditions of chronic caloric excess, the liver may convert surplus carbohydrates into fatty acids through a process known as de novo lipogenesis. These fatty acids can then be stored as triglycerides within hepatocytes.

Over time, this accumulation may contribute to metabolic dysfunction.

**MASLD and Metabolic Syndrome**

Fatty liver disease frequently appears alongside other features of metabolic syndrome.

Individuals with MASLD often show:

• insulin resistance

• elevated triglycerides

• reduced HDL cholesterol

• abdominal obesity

• hypertension

Because of these associations, many researchers now view MASLD as part of a broader metabolic disorder rather than a purely liver-specific disease.

The presence of liver fat may therefore serve as an early marker of systemic metabolic stress.

**Disease Progression**

In many individuals, liver steatosis remains relatively stable. However, in some cases fatty liver can progress to more severe stages of liver injury.

Possible stages include:

1. Simple steatosis – fat accumulation without significant inflammation
2. Steatohepatitis – inflammation and liver cell injury
3. Fibrosis – development of scar tissue
4. Cirrhosis – advanced scarring that disrupts liver structure and function

Progression occurs gradually and varies among individuals. However, there is now literature showing an increased link of cirrhosis casued by MASLD and cancers of the liver

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/05/Screenshot-2026-05-17-at-10.25.07---AM-1.png)

**Global Prevalence**

MASLD has become increasingly common in many regions of the world. Rising rates of obesity, insulin resistance, and metabolic syndrome have contributed to the growing prevalence of fatty liver disease.

In some countries, estimates suggest that roughly one quarter of adults may have some degree of liver steatosis.

Because the condition often produces few symptoms in early stages, many individuals may remain unaware of the disease until it is detected through imaging or laboratory testing.

**Prevention and Management**

Management of MASLD typically focuses on addressing the metabolic factors that contribute to liver fat accumulation.

Common approaches include:

• weight reduction when appropriate

• improved diet quality

• increased physical activity

• management of blood glucose and lipid levels

In many individuals, even modest improvements in metabolic health can reduce liver fat and improve liver function.

**Related Topics**

Readers interested in the broader metabolic context of fatty liver disease may wish to explore:

**•** [**GLUT 5**](https://www.internets.com/fructose-science-glut5)

**•** [**Fructose Metabolism**](https://www.internets.com/fructose-science-fructose)

**• I**[**nsulin Resistance**](https://www.internets.com/fructose-science-insulin-resistance)

**•** [**Global Metabolic Crisis**](https://www.internets.com/global-metabolic-crisis)

These topics examine the metabolic processes that often accompany MASLD.

## Related Metabolic Disease Pages

For a plain-language companion, see [MASLD Explained Simply](https://www.internets.com/metabolic-disease-masld-explained/). For the diagnostic cluster that often travels with fatty liver, see [Metabolic Syndrome Criteria](https://www.internets.com/metabolic-disease-metabolic-syndrome-definition/).

## Related Screening Page

For practical fibrosis-risk context, see [MASLD screening with FIB-4 and liver stiffness](https://www.internets.com/metabolic-disease-masld-screening-fib-4-liver-stiffness/).

## Related Treatment Pages

For current treatment context, see [MASH treatment with resmetirom, semaglutide, and MASLD care](https://www.internets.com/metabolic-disease-mash-resmetirom-treatment/) and [GLP-1 and GIP therapy](https://www.internets.com/metabolic-disease-glp-1-gip-therapy-semaglutide-tirzepatide/).
### Insulin Resistance
URL: https://www.internets.com/fructose-science-insulin-resistance/
Last updated: 2026-08-17T09:04:23.000Z
Subsection Navigation  

Core and Overview: [Overview](https://www.internets.com/fructose-science/) • [Metabolic Syndrome Biochemistry](https://www.internets.com/fructose-science-metabolic-syndrome-biochemistry/) • [Fructose Evolution / Thrifty Pathway](https://www.internets.com/fructose-science-fructose-evolution-thrifty-pathway/)  | Fructose Pathway: [Fructose vs Glucose](https://www.internets.com/fructose-science-fructose-vs-glucose/) • [GLUT5](https://www.internets.com/fructose-science-glut5/) • [KHK](https://www.internets.com/fructose-science-khk/) • [Fructose Metabolism](https://www.internets.com/fructose-science-fructose-metabolism/) • [Liver Metabolic Gate](https://www.internets.com/fructose-science-liver-metabolic-gate/) • [ATP Depletion](https://www.internets.com/fructose-science-atp-depletion/) • [Uric Acid Biochemistry](https://www.internets.com/fructose-science-uric-acid-biochemistry/) • [De Novo Lipogenesis](https://www.internets.com/fructose-science-de-novo-lipogenesis/) • [HFCS](https://www.internets.com/fructose-science-hfcs/) • [ALT](https://www.internets.com/fructose-science-what-is-alt-alanine-aminotransferase/)  | Hormones and Regulation: [Insulin Signaling](https://www.internets.com/fructose-science-insulin-signaling/) • [Insulin Resistance](https://www.internets.com/fructose-science-insulin-resistance/) • [Adipokines & Hormones](https://www.internets.com/fructose-science-adipokines-hormones/) • [Leptin](https://www.internets.com/fructose-science-leptin/) • [Ghrelin](https://www.internets.com/fructose-science-ghrelin/) • [Asprosin](https://www.internets.com/fructose-science-asprosin/) • [Adiponectin](https://www.internets.com/fructose-science-adiponectin-metabolic-protection/) 

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-11.42.22---AM.png)

Insulin resistance is a metabolic condition in which the body’s tissues respond less effectively to the hormone insulin. Because insulin plays a central role in regulating blood glucose, reduced sensitivity to this hormone can disrupt multiple metabolic pathways.

Insulin resistance is widely recognized as one of the central biological processes underlying metabolic syndrome, type 2 diabetes, and several related disorders. It is also closely associated with obesity, fatty liver disease, and cardiovascular risk.

Understanding insulin resistance is therefore essential for understanding modern metabolic disease.

### **The Role of Insulin**

Insulin is a hormone produced by the pancreas in response to rising blood glucose levels after a meal. Its primary function is to help cells absorb glucose from the bloodstream and use it for energy.

Insulin also influences several other metabolic processes, including:

• storage of glucose as glycogen in the liver and muscles

• regulation of lipid metabolism

• inhibition of glucose production by the liver

In healthy metabolic conditions, insulin signaling maintains stable blood glucose levels while coordinating energy storage and utilization.

### **What Happens in Insulin Resistance**

When insulin resistance develops, cells in the liver, muscle, and adipose tissue become less responsive to insulin signals.

As a result:

• glucose uptake by tissues decreases

• the liver continues producing glucose even when it is not needed

• circulating insulin levels increase as the pancreas attempts to compensate

Over time, the pancreas may struggle to maintain this increased insulin production. When this occurs, blood glucose levels begin to rise, eventually leading to prediabetes or type 2 diabetes.

### **Relationship to Visceral Fat**

Insulin resistance is strongly associated with visceral adiposity, the accumulation of fat around abdominal organs.

Visceral adipose tissue releases fatty acids and signaling molecules that influence inflammation and metabolic regulation. These signals can interfere with insulin signaling pathways and promote metabolic dysfunction.

As visceral fat increases, insulin resistance often becomes more pronounced.

**The Liver and Insulin Resistance**

The liver plays a critical role in glucose regulation. Under normal conditions, insulin suppresses the liver’s production of glucose between meals.

In insulin-resistant states, this suppression becomes less effective. The liver may continue producing glucose even when blood glucose levels are already elevated.

At the same time, excess nutrients may be converted into triglycerides within the liver, contributing to fatty liver disease. This process further amplifies metabolic dysfunction.

### **Early and Silent Development**

Insulin resistance often develops gradually and may remain undetected for many years.

During early stages, the body compensates by producing higher levels of insulin. Blood glucose levels may remain within normal ranges despite significant metabolic changes.

Eventually, however, this compensation may fail. Rising glucose levels then signal the transition toward prediabetes or type 2 diabetes.

Because of this long silent phase, insulin resistance is often well established before clinical disease becomes apparent.

### **Environmental Influences**

Several environmental factors contribute to the development of insulin resistance:

• excess caloric intake

• diets high in refined carbohydrates and added sugars

• sedentary lifestyle

• chronic stress

• sleep disruption

These influences interact with genetic susceptibility and metabolic physiology to shape individual risk.

### **Prevention and Management**

Interventions aimed at improving metabolic health can often improve insulin sensitivity.

These may include:

• increased physical activity

• improved dietary patterns

• reduction of visceral adiposity

• improved sleep and stress regulation

In some cases, medications are also used to help manage glucose regulation.

Because insulin resistance lies near the center of metabolic disease, addressing it can have broad effects on overall metabolic health.

## **Related Topics**

Readers interested in exploring the metabolic pathways connected to insulin resistance may also consult:

[Fasting Glucose](https://www.internets.com/clinical-resources-fasting-glucose)  
[HbA1c](https://www.internets.com/clinical-resources-hba1c)  
[Prediabetes](https://www.internets.com/metabolic-disease-prediabetes/)  
[Type 2 Diabetes](https://www.internets.com/metabolic-disease-type-2-diabetes)  
[Metabolic Syndrome](https://www.internets.com/metabolic-disease-biology-of-metabolic-disease/)

These topics examine the biological processes that frequently accompany insulin resistance.

## 2026 Repository Update

**Summary:** Insulin resistance is the central bridge between Fructose Science and Metabolic Disease. It links fatty liver, high triglycerides, prediabetes, type 2 diabetes, hypertension, low HDL cholesterol, visceral adiposity, MASLD, CKD risk, and cardiovascular disease.

The 2026 CKM framework strengthens that bridge by treating cardiovascular, kidney, and metabolic disease as an interconnected syndrome. Fructose biology fits into this model because hepatic ATP stress, uric acid production, de novo lipogenesis, liver fat, and inflammatory signaling can all worsen the insulin-resistant phenotype in susceptible people.

**Sources:** JACC, [2026 CKM Syndrome Guideline Hub](https://www.jacc.org/guidelines/cardiovascular-kidney-metabolic?ref=internets.com); Li Z. et al., fructose metabolism review, [PMID 40549205](https://pubmed.ncbi.nlm.nih.gov/40549205/?ref=internets.com).
### De Novo Lipogenesis, Liver Fat
URL: https://www.internets.com/fructose-science-de-novo-lipogenesis/
Last updated: 2026-08-17T09:57:22.000Z
Subsection Navigation  

Core and Overview: [Overview](https://www.internets.com/fructose-science/) • [Metabolic Syndrome Biochemistry](https://www.internets.com/fructose-science-metabolic-syndrome-biochemistry/) • [Fructose Evolution / Thrifty Pathway](https://www.internets.com/fructose-science-fructose-evolution-thrifty-pathway/)  | Fructose Pathway: [Fructose vs Glucose](https://www.internets.com/fructose-science-fructose-vs-glucose/) • [GLUT5](https://www.internets.com/fructose-science-glut5/) • [KHK](https://www.internets.com/fructose-science-khk/) • [Fructose Metabolism](https://www.internets.com/fructose-science-fructose-metabolism/) • [Liver Metabolic Gate](https://www.internets.com/fructose-science-liver-metabolic-gate/) • [ATP Depletion](https://www.internets.com/fructose-science-atp-depletion/) • [Uric Acid Biochemistry](https://www.internets.com/fructose-science-uric-acid-biochemistry/) • [De Novo Lipogenesis](https://www.internets.com/fructose-science-de-novo-lipogenesis/) • [HFCS](https://www.internets.com/fructose-science-hfcs/) • [ALT](https://www.internets.com/fructose-science-what-is-alt-alanine-aminotransferase/)  | Hormones and Regulation: [Insulin Signaling](https://www.internets.com/fructose-science-insulin-signaling/) • [Insulin Resistance](https://www.internets.com/fructose-science-insulin-resistance/) • [Adipokines & Hormones](https://www.internets.com/fructose-science-adipokines-hormones/) • [Leptin](https://www.internets.com/fructose-science-leptin/) • [Ghrelin](https://www.internets.com/fructose-science-ghrelin/) • [Asprosin](https://www.internets.com/fructose-science-asprosin/) • [Adiponectin](https://www.internets.com/fructose-science-adiponectin-metabolic-protection/) 

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/05/Screenshot-2026-05-17-at-6.52.16---AM.png)

## **Introduction**

De novo lipogenesis is the metabolic process through which the body converts excess carbohydrates into fatty acids. Although this pathway occurs in several tissues, it is most active in the liver.

Under normal conditions, de novo lipogenesis contributes modestly to the body’s overall fat production. However, when carbohydrate intake is consistently high and energy needs are already met, this pathway can become more active. In such circumstances the liver may convert excess carbohydrate substrates into triglycerides, which can accumulate within liver cells or be exported into the bloodstream.

Because of its role in hepatic fat accumulation, de novo lipogenesis has become an important topic in research on metabolic disease and fatty liver.

**Carbohydrates and Lipid Synthesis**

When carbohydrates are consumed, they are broken down into simple sugars such as glucose and fructose. These molecules enter metabolic pathways that provide energy for cellular processes.

If energy demands are satisfied and glycogen stores are already filled, surplus carbohydrate substrates may be diverted toward lipid synthesis. Through a series of enzymatic reactions, the liver converts these substrates into fatty acids.

These fatty acids are then assembled into triglycerides, which may be:

• stored temporarily within liver cells

• exported into circulation as very-low-density lipoproteins (VLDL)

• transported to adipose tissue for long-term storage

This process allows the body to convert excess carbohydrate energy into fat.

**The Liver as a Metabolic Hub**

The liver occupies a central position in metabolic regulation. Nutrients absorbed from the intestine enter the portal circulation, which delivers them directly to the liver before they reach the rest of the body.

Because of this arrangement, the liver receives high concentrations of dietary carbohydrates shortly after meals. This exposure allows the liver to determine how these nutrients are processed, stored, or distributed.

When carbohydrate intake is frequent or excessive, the liver may respond by increasing lipogenesis.

**Fructose and Lipogenesis**

Fructose metabolism has attracted particular attention in studies of hepatic lipid synthesis.

Unlike glucose, fructose metabolism in the liver bypasses certain regulatory steps that normally help control carbohydrate processing. As a result, fructose can be converted into metabolic intermediates that feed directly into lipid synthesis pathways.

Experimental studies have shown that high fructose exposure can stimulate enzymes involved in de novo lipogenesis. These effects may increase triglyceride production within the liver.

The extent to which this mechanism contributes to metabolic disease remains an active area of research.

**Liver Fat Accumulation**

When triglyceride production within the liver exceeds the liver’s ability to export or oxidize fatty acids, fat may begin to accumulate within hepatocytes.

This accumulation is known as hepatic steatosis, or fatty liver.

Several processes can contribute to liver fat accumulation:

• increased de novo lipogenesis

• increased delivery of fatty acids from adipose tissue

• reduced fatty acid oxidation

• impaired export of triglycerides

Fat accumulation within the liver is a defining feature of metabolic dysfunction–associated steatotic liver disease (MASLD).

**Lipids in Circulation**

Triglycerides synthesized in the liver can also be packaged into very-low-density lipoprotein (VLDL) particles and released into the bloodstream.

Elevated VLDL production contributes to increased circulating triglyceride levels, a common feature of metabolic syndrome.

These lipid changes can influence cardiovascular risk by affecting cholesterol transport and arterial health.

**Metabolic Context**

De novo lipogenesis is only one component of the metabolic processes associated with fatty liver disease.

Other factors that influence liver fat include:

• insulin resistance

• visceral adiposity

• chronic caloric excess

• genetic susceptibility

• dietary composition

Because these processes interact, fatty liver disease is increasingly viewed as part of a broader metabolic disorder rather than an isolated liver condition.

**Ongoing Research**

Researchers continue to study the role of hepatic lipogenesis in metabolic disease.

Questions under investigation include:

• how different dietary patterns influence lipogenesis

• the relative contribution of fructose and glucose metabolism

• genetic factors affecting lipid synthesis pathways

• potential interventions that may reduce hepatic fat accumulation

Understanding these mechanisms may help clarify the biological pathways linking diet, liver metabolism, and cardiometabolic disease.

**Related Topics**

Readers interested in the metabolic pathways discussed on this page may also explore:

**•** [**Fructose Metabolism**](https://www.internets.com/fructose=science/)

**•**[ **Insulin Resistance**](https://www.internets.com/metabolic-disease/insulin-resistance)

**•** [**ATP Depletion**](https://www.internets.com/fructose-science-atp-depletion/)

**•** [**Metabolic Syndrome**](https://www.internets.com/metabolic-disease/metabolic-syndrome)

These pages examine the broader physiological context of hepatic lipid metabolism.

## 2025-2026 Evidence Update

**Summary:** De novo lipogenesis remains one of the key bridges between excess refined carbohydrate exposure and fatty liver biology. Fructose is especially important because hepatic fructose handling can bypass some of the tighter regulatory steps that apply to glucose, increasing pressure on ATP balance, uric acid production, triglyceride synthesis, and liver fat accumulation.

The newer MASLD literature makes this pathway more clinically visible. The 2026 ADA Standards of Care describe MASLD risk stratification with FIB-4 followed by liver stiffness measurement when FIB-4 is elevated, and discuss emerging treatments such as GLP-1 receptor agonists, tirzepatide data, and resmetirom for selected patients with F2-F3 fibrosis. For this page, the practical point is that de novo lipogenesis is not just biochemistry; it is part of the road from diet and insulin resistance to measurable liver risk.

**Sources:** ADA Standards of Care in Diabetes 2026, [MASLD assessment and treatment section](https://diabetesjournals.org/care/article/49/Supplement%5F1/S61/163931/4-Comprehensive-Medical-Evaluation-and-Assessment?ref=internets.com); Li Z. et al., [PMID 40549205](https://pubmed.ncbi.nlm.nih.gov/40549205/?ref=internets.com).

## Related Treatment Page

For how fatty-liver biology now connects to clinical treatment pathways, see [MASH treatment: resmetirom, semaglutide, and MASLD care](https://www.internets.com/metabolic-disease-mash-resmetirom-treatment/).
### Metabolic Syndrome and Cardiovascular Disease
URL: https://www.internets.com/metabolic-disease-cardiovascular-disease/
Last updated: 2026-08-17T09:57:10.000Z
Subsection Navigation 

Core Pages: [Fructose Disease Arc](https://www.internets.com/metabolic-disease-fructose-disease-arc/) • [Metabolic Disease](https://www.internets.com/metabolic-disease/) • [Metabolic Syndrome (Biochemistry)](https://www.internets.com/metabolic-disease-metabolic-syndrome-biochemistry/) • [Metabolic Syndrome (Clinical)](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)  | Body Fat and Metabolic Drivers: [Visceral Adiposity & Inflammatory Signaling](https://www.internets.com/metabolic-disease-visceral-adiposity-and-inflammatory-signaling/) • [Cardio-Hepatic Axis](https://www.internets.com/metabolic-disease-cardio-hepatic-axis/) • [Inflammation](https://www.internets.com/metabolic-disease-inflammation/)  | Lipid and Metabolic Risk: [Cholesterol](https://www.internets.com/metabolic-disease-what-is-cholesterol/) • [Triglycerides](https://www.internets.com/metabolic-disease-triglycerides-cardiovascular-risk/) • [LDL](https://www.internets.com/metabolic-disease-small-dense-ldl/) • [HDL](https://www.internets.com/metabolic-disease-hdl-cholesterol/)  | Clinical Disease Expression: [Dyslipidemia](https://www.internets.com/metabolic-disease-dyslipidemia/) • [Obesity](https://www.internets.com/metabolic-disease-obesity/) • [Fatty Liver](https://www.internets.com/metabolic-disease-masld/) • [Prediabetes](https://www.internets.com/metabolic-disease-prediabetes/) • [Type 2 Diabetes](https://www.internets.com/metabolic-disease-type-2-diabetes/) • [Hypertension](https://www.internets.com/metabolic-disease-hypertension/) • [Cardiovascular Disease](https://www.internets.com/metabolic-disease-cardiovascular-disease/) • [Sleep Apnea](https://www.internets.com/metabolic-disease-sleep-apnea/) • [HFpEF](https://www.internets.com/metabolic-disease-hfpef/) • [Hyperuricemia](https://www.internets.com/metabolic-disease-hyperuricemia/) • [Renal Failure](https://www.internets.com/metabolic-disease-renal-failure/) • [Gut Microbiome](https://www.internets.com/metabolic-disease-gut-microbiome-metabolism/) • [Renin-Angiotensin System](https://www.internets.com/renin/)  | Special Topics: [Dementia](https://www.internets.com/metabolic-disease-dementia/) • [Fructose & Cancer Metabolism](https://www.internets.com/fructose-science-fructose-cancer-metabolism/) • [Warburg Effect](https://www.internets.com/metabolic-disease-fructose-warburg-effect/)  | Reversal and Recovery: [Reversal with Diet](https://www.internets.com/metabolic-disease-reversal/) • [Reversal with Drugs](https://www.internets.com/clinical-resources-reversal-with-drugs-md/) 

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-8.30.26---AM.png)

Cardiovascular disease remains one of the leading causes of death worldwide. Heart attacks, strokes, heart failure, and other vascular disorders account for a substantial portion of global mortality.

Over the past several decades, researchers have increasingly recognized that many forms of cardiovascular disease are closely linked with metabolic dysfunction. Conditions such as obesity, insulin resistance, fatty liver disease, and dyslipidemia frequently precede the development of cardiovascular complications.

Metabolic syndrome represents one of the clearest examples of this relationship. Individuals with metabolic syndrome face significantly higher risks of coronary artery disease, stroke, and other vascular disorders.

Understanding how metabolic disturbances affect the cardiovascular system is therefore essential for understanding modern patterns of heart disease.

## **The Metabolic–Cardiovascular Connection**

The cardiovascular system is highly sensitive to metabolic changes.

Several features of metabolic syndrome influence cardiovascular health:

• elevated triglycerides

• reduced HDL cholesterol

• insulin resistance

• chronic low-grade inflammation

• elevated blood pressure

Together these factors contribute to conditions that can damage blood vessels and accelerate the development of atherosclerosis, the buildup of fatty plaques within arterial walls.

Over time, these plaques can narrow arteries or rupture, leading to heart attacks and strokes.

## **Dyslipidemia**

One of the most important cardiovascular risk factors associated with metabolic syndrome is dyslipidemia, an abnormal pattern of circulating lipids.

This pattern often includes:

• elevated triglycerides

• reduced HDL cholesterol

• increased numbers of small, dense LDL particles

These lipid abnormalities can promote plaque formation within arteries and increase the likelihood of vascular complications.

Because lipid metabolism is closely linked to liver function and insulin signaling, dyslipidemia often appears alongside other metabolic disturbances.

## **Inflammation and Vascular Injury**

Metabolic syndrome is also associated with chronic low-grade inflammation.

Visceral adipose tissue releases inflammatory signaling molecules that circulate throughout the body. These molecules can affect the lining of blood vessels, known as the endothelium.

Endothelial dysfunction may impair the ability of blood vessels to regulate blood flow and maintain normal vascular tone. Over time this dysfunction can contribute to plaque formation and arterial stiffness.

Inflammatory signaling therefore represents another pathway linking metabolic disease to cardiovascular risk.

## **Hypertension**

Elevated blood pressure frequently accompanies metabolic syndrome.

Several mechanisms may contribute to this relationship, including:

• increased sympathetic nervous system activity

• altered kidney sodium handling

• vascular stiffness

• metabolic signaling pathways involving insulin and adipose tissue

Persistent hypertension places mechanical stress on blood vessels and the heart, further increasing cardiovascular risk.

## **Fatty Liver and Cardiovascular Risk**

Fatty liver disease is increasingly recognized as a marker of cardiometabolic risk.

Individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) often show higher rates of insulin resistance, dyslipidemia, and systemic inflammation. These factors contribute to the development of cardiovascular disease.

In many cases, cardiovascular complications become the leading cause of mortality among individuals with fatty liver disease.

For this reason, clinicians often consider liver fat accumulation as part of the broader metabolic picture rather than a condition limited to the liver itself.

## **A Systemic Disorder**

The relationship between metabolic syndrome and cardiovascular disease illustrates an important principle: metabolic disease is fundamentally systemic.

The liver, pancreas, adipose tissue, vascular system, and endocrine signaling networks all participate in metabolic regulation. When these systems are disrupted, the consequences extend well beyond any single organ.

Viewing cardiovascular disease through this metabolic lens helps explain why prevention strategies often focus on improving overall metabolic health.

## **Prevention and Risk Reduction**

Reducing cardiovascular risk in individuals with metabolic syndrome typically involves addressing the underlying metabolic disturbances.

Common approaches include:

• improving dietary patterns

• increasing physical activity

• reducing visceral adiposity

• managing blood pressure and lipid levels

• improving insulin sensitivity

Medical therapies may also be used when appropriate to control cholesterol, blood pressure, or glucose levels.

Early intervention can significantly reduce the likelihood of cardiovascular complications.

## **Related Topics**

Readers interested in exploring the metabolic pathways connected to cardiovascular disease may also consult:

**•** [**De Novo Lipogenesis**](https://www.internets.com/fructose-science-de=novo=lipogenesis)

**•** [**Cardio-hepatic Axis**](https://www.internets.com/metabolic-disease-cardio-hepatic-axis/)

**•** [**Metabolic Syndrome**](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)

These pages examine the metabolic mechanisms that frequently precede cardiovascular complications.

## 2026 Evidence Update

**Summary:** Cardiovascular disease prevention is increasingly being framed through the combined cardiovascular-kidney-metabolic system. The 2026 AHA/ACC/ADA/ASN guideline describes CKM syndrome as an interconnected disease state in which obesity, type 2 diabetes, chronic kidney disease, and cardiovascular disease reinforce one another.

For this page, the GEO-friendly answer is direct: metabolic syndrome increases cardiovascular risk because abdominal obesity, insulin resistance, high triglycerides, low HDL cholesterol, hypertension, fatty liver, kidney stress, and inflammation often travel together. Treating blood pressure or LDL cholesterol alone may be necessary, but the larger disease pattern also requires attention to weight, glucose metabolism, kidney function, triglycerides, diet quality, sleep, and physical activity.

**Sources:** 2026 AHA/ACC/ADA/ASN CKM guideline summary, [JACC Guideline-at-a-Glance](https://www.jacc.org/doi/10.1016/j.jacc.2026.05.008?ref=internets.com); American Heart Association, [CKM guideline news release](https://newsroom.heart.org/news/first-ever-guideline-on-cardiovascular-kidney-metabolic-syndrome-issued?ref=internets.com).

## Related Framework

For the guideline framework linking cardiovascular disease with kidney disease, obesity, diabetes, MASLD, and metabolic syndrome, see [Cardiovascular-Kidney-Metabolic Syndrome](https://www.internets.com/metabolic-disease-cardiovascular-kidney-metabolic-syndrome/).

## Related Lipid Marker Page

For a focused explanation of particle burden in metabolic cardiovascular risk, see [ApoB, non-HDL cholesterol, and atherogenic dyslipidemia](https://www.internets.com/metabolic-disease-apob-non-hdl-cholesterol-atherogenic-dyslipidemia/).

## Related Treatment Pages

For current metabolic-cardiovascular treatment context, see [GLP-1 and GIP therapy](https://www.internets.com/metabolic-disease-glp-1-gip-therapy-semaglutide-tirzepatide/) and [SGLT2 inhibitors for kidney and heart protection](https://www.internets.com/metabolic-disease-sglt2-inhibitors-kidney-heart-protection/).
### The Cardio-Hepatic Axis
URL: https://www.internets.com/metabolic-disease-cardio-hepatic-axis/
Last updated: 2026-05-21T17:21:46.000Z
Subsection Navigation 

Core Pages: [Fructose Disease Arc](https://www.internets.com/metabolic-disease-fructose-disease-arc/) • [Metabolic Disease](https://www.internets.com/metabolic-disease/) • [Metabolic Syndrome (Biochemistry)](https://www.internets.com/metabolic-disease-metabolic-syndrome-biochemistry/) • [Metabolic Syndrome (Clinical)](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)  | Body Fat and Metabolic Drivers: [Visceral Adiposity & Inflammatory Signaling](https://www.internets.com/metabolic-disease-visceral-adiposity-and-inflammatory-signaling/) • [Cardio-Hepatic Axis](https://www.internets.com/metabolic-disease-cardio-hepatic-axis/) • [Inflammation](https://www.internets.com/metabolic-disease-inflammation/)  | Lipid and Metabolic Risk: [Cholesterol](https://www.internets.com/metabolic-disease-what-is-cholesterol/) • [Triglycerides](https://www.internets.com/metabolic-disease-triglycerides-cardiovascular-risk/) • [LDL](https://www.internets.com/metabolic-disease-small-dense-ldl/) • [HDL](https://www.internets.com/metabolic-disease-hdl-cholesterol/)  | Clinical Disease Expression: [Dyslipidemia](https://www.internets.com/metabolic-disease-dyslipidemia/) • [Obesity](https://www.internets.com/metabolic-disease-obesity/) • [Fatty Liver](https://www.internets.com/metabolic-disease-masld/) • [Prediabetes](https://www.internets.com/metabolic-disease-prediabetes/) • [Type 2 Diabetes](https://www.internets.com/metabolic-disease-type-2-diabetes/) • [Hypertension](https://www.internets.com/metabolic-disease-hypertension/) • [Cardiovascular Disease](https://www.internets.com/metabolic-disease-cardiovascular-disease/) • [Sleep Apnea](https://www.internets.com/metabolic-disease-sleep-apnea/) • [HFpEF](https://www.internets.com/metabolic-disease-hfpef/) • [Hyperuricemia](https://www.internets.com/metabolic-disease-hyperuricemia/) • [Renal Failure](https://www.internets.com/metabolic-disease-renal-failure/) • [Gut Microbiome](https://www.internets.com/metabolic-disease-gut-microbiome-metabolism/) • [Renin-Angiotensin System](https://www.internets.com/renin/)  | Special Topics: [Dementia](https://www.internets.com/metabolic-disease-dementia/) • [Fructose & Cancer Metabolism](https://www.internets.com/fructose-science-fructose-cancer-metabolism/) • [Warburg Effect](https://www.internets.com/metabolic-disease-fructose-warburg-effect/)  | Reversal and Recovery: [Reversal with Diet](https://www.internets.com/metabolic-disease-reversal/) • [Reversal with Drugs](https://www.internets.com/clinical-resources-reversal-with-drugs-md/) 

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-1.11.00---PM.png)

The liver and the cardiovascular system are closely linked through metabolic regulation. In recent years, researchers have increasingly recognized that disturbances in liver metabolism can influence cardiovascular health in important ways.

This relationship is sometimes described as the cardio-hepatic axis. The concept reflects the idea that metabolic processes occurring in the liver can affect lipid metabolism, inflammatory signaling, vascular function, and ultimately the development of cardiovascular disease.

Because metabolic disorders frequently involve both hepatic and cardiovascular systems, understanding this connection is essential for explaining modern patterns of cardiometabolic disease.

**The Liver as a Metabolic Control Center**

The liver occupies a central position in the body’s metabolic network. It processes nutrients absorbed from the intestine, regulates glucose production, synthesizes lipids, and produces many proteins involved in circulation and immune function.

After a meal, nutrients travel from the intestine to the liver through the portal vein, exposing the liver to high concentrations of carbohydrates, fats, and other dietary substrates.

The liver then determines how these nutrients are distributed throughout the body. It may convert carbohydrates into glycogen for storage, synthesize fatty acids, or package lipids into lipoproteins that circulate through the bloodstream.

Because of these roles, disturbances in liver metabolism can influence systemic metabolic balance.

**Lipid Metabolism and Cardiovascular Risk**

One of the most important connections between the liver and cardiovascular disease involves lipid metabolism.

The liver synthesizes triglycerides and packages them into very-low-density lipoprotein (VLDL) particles. These lipoproteins circulate through the bloodstream and eventually contribute to the formation of low-density lipoprotein (LDL), a key component of atherosclerotic plaque.

When liver metabolism becomes disrupted—through insulin resistance, fatty liver disease, or metabolic overload—lipid production and lipoprotein composition may change.

These alterations can increase circulating triglycerides and promote the formation of atherogenic lipoprotein particles.

**Fatty Liver and Cardiovascular Disease**

Fatty liver disease has become one of the most common metabolic disorders worldwide. In many individuals, hepatic fat accumulation occurs alongside obesity, insulin resistance, and metabolic syndrome.

Studies increasingly show that individuals with metabolic dysfunction–associated steatotic liver disease (MASLD) face higher risks of cardiovascular disease compared with those without liver fat.

In fact, cardiovascular complications are often the leading cause of death among individuals with fatty liver disease.

This observation highlights the importance of viewing liver health within the broader context of cardiometabolic disease.

**Inflammatory Signaling**

The liver also participates in systemic inflammatory regulation.

Hepatocytes and immune cells within the liver produce several proteins involved in inflammatory signaling, including C-reactive protein (CRP) and other acute-phase reactants.

In metabolic disease, chronic low-grade inflammation may develop within both adipose tissue and the liver. These inflammatory signals can influence vascular function and contribute to endothelial dysfunction.

Over time, inflammatory processes may accelerate the development of atherosclerosis and vascular injury.

**Insulin Resistance and the Liver**

Insulin resistance affects multiple organs, but the liver plays a particularly important role in glucose regulation.

When hepatic insulin signaling becomes impaired, the liver may continue producing glucose even when blood glucose levels are already elevated. At the same time, lipid synthesis pathways may become more active.

These changes can contribute to both hyperglycemia and dyslipidemia, two major risk factors for cardiovascular disease.

The liver therefore acts as a key intermediary between metabolic disturbances and vascular outcomes.

**A Systems Perspective**

The cardio-hepatic axis illustrates the importance of viewing metabolic disease as a systems disorder.

The liver, adipose tissue, pancreas, and cardiovascular system operate within an interconnected network of metabolic signaling pathways. When one component becomes dysregulated, the effects often propagate through multiple organ systems.

Recognizing these interactions allows clinicians and researchers to better understand why metabolic disorders frequently lead to cardiovascular complications.

## Fructose as a second hit hypothesis.

This is a hypothesis only, based on Dr Gregor's research on Western diet effect on ethnicities most prone to liver damage from modern high sugar food, but with a background on right heart failure and passive congestion of the liver. 

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/05/Screenshot-2026-05-21-at-9.32.23---AM.png)

**Clinical Implications**

For clinicians, the cardio-hepatic axis highlights the value of assessing metabolic health when evaluating cardiovascular risk.

Markers such as liver fat accumulation, elevated triglycerides, insulin resistance, and inflammatory biomarkers may all provide insight into cardiometabolic risk.

Addressing metabolic dysfunction early—through lifestyle modification and appropriate medical management—may help reduce the long-term burden of cardiovascular disease.

**Related Topics**

Readers interested in exploring the metabolic processes discussed on this page may also consult:

**•** [**Metabolic Syndrome**](https://www.internets.com/metabolic-disease-metabolic-syncrome)

**•** [**Fatty Liver Disease (MASLD)**](https://www.internets.com/metabolic-disease-masld)

**•** [**De Novo Lipogenesis**](https://www.internets.com/fructose-science-de-novo-lipogenesis/)

**•** [**Cardiovascular Disease**](https://www.internets.com/metabolic-disease-cardiovascular-disease/)

These topics examine the biological pathways that link liver metabolism to cardiovascular disease.
### ATP Depletion and Cellular Energy Stress
URL: https://www.internets.com/fructose-science-atp-depletion/
Last updated: 2026-07-08T01:55:15.000Z
![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-9.05.39---AM.png)

Adenosine triphosphate (ATP) is the primary energy carrier within human cells. Nearly every biological process that requires energy—from muscle contraction to protein synthesis—depends on the availability of ATP.

Because ATP is so central to cellular function, changes in ATP balance can influence many metabolic pathways. When ATP levels decline within a cell, a series of compensatory biochemical responses may be activated to restore energy balance.

In metabolic research, ATP depletion has received particular attention in studies of carbohydrate metabolism, especially in relation to fructose processing in the liver. Investigating how cellular energy balance is affected by nutrient metabolism helps illuminate the broader physiology of metabolic stress.

**ATP as the Cell’s Energy Currency**

ATP functions as the universal energy molecule of living cells. It stores energy within high-energy phosphate bonds that can be released when the molecule is hydrolyzed.

When ATP loses one phosphate group it becomes adenosine diphosphate (ADP). Additional breakdown produces adenosine monophosphate (AMP).

These transformations allow cells to convert stored chemical energy into usable work for metabolic reactions.

To maintain normal function, cells continuously regenerate ATP through metabolic pathways such as:

• glycolysis

• oxidative phosphorylation

• fatty acid oxidation

• the citric acid cycle

Under stable conditions, ATP production and ATP consumption remain in balance.

**Rapid ATP Consumption During Fructose Metabolism**

When fructose enters the liver, it is metabolized rapidly by the enzyme ketohexokinase (KHK).

This enzyme catalyzes the phosphorylation of fructose to form fructose-1-phosphate, a reaction that requires ATP. Unlike several steps in glucose metabolism, this reaction is not tightly regulated by feedback mechanisms.

Because of this lack of regulation, large quantities of fructose can be phosphorylated quickly within hepatocytes. During periods of high fructose exposure, this process can transiently reduce intracellular ATP levels.

Although liver cells typically restore ATP levels through metabolic compensation, repeated exposure to large substrate loads can generate temporary energy stress within hepatic cells.

**Adenine Nucleotide Breakdown**

When intracellular ATP levels decline, adenine nucleotides may be degraded in order to maintain cellular energy balance.

This breakdown process produces several intermediate compounds, eventually leading to the formation of uric acid.

For this reason, researchers have proposed that rapid ATP depletion during fructose metabolism may contribute to increased uric acid production.

The relationship between ATP depletion, nucleotide degradation, and uric acid generation remains an important topic in metabolic research.

**Cellular Energy Sensors**

Cells possess several molecular systems that detect changes in energy balance. One of the most important of these systems involves AMP-activated protein kinase (AMPK).

AMPK functions as a cellular energy sensor. When ATP levels decline and AMP levels rise, AMPK becomes activated. This activation triggers metabolic adjustments designed to restore energy balance.

These adjustments may include:

• increasing energy production pathways

• reducing energy-consuming processes

• promoting fatty acid oxidation

• altering glucose metabolism

Through these mechanisms, cells attempt to stabilize their internal energy state.

**Energy Stress and Metabolic Signaling**

Cellular energy balance influences numerous metabolic pathways.

When ATP depletion occurs repeatedly or chronically, metabolic signaling networks may adapt in ways that affect lipid metabolism, glucose regulation, and inflammatory pathways.

Some researchers have proposed that these energy-sensing pathways could contribute to broader metabolic changes associated with insulin resistance and fatty liver disease.

Although many details remain under investigation, the concept of cellular energy stress provides a useful framework for understanding how nutrient metabolism may influence systemic physiology.

**The Liver and Energy Regulation**

The liver plays a central role in managing cellular energy balance after meals.

Because it receives nutrients directly from the intestine through the portal circulation, the liver must rapidly process incoming carbohydrates, fats, and amino acids. These metabolic reactions influence ATP production and consumption within hepatocytes.

When nutrient exposure is excessive or frequent, hepatic energy metabolism may be placed under greater demand. The resulting changes in ATP dynamics may influence downstream metabolic signaling pathways.

**Research Perspectives**

The relationship between ATP depletion, fructose metabolism, uric acid production, and metabolic disease remains an active field of scientific investigation.

Researchers continue to study:

• how different nutrients affect cellular energy balance

• the role of ATP depletion in metabolic signaling

• interactions between hepatic metabolism and systemic physiology

• the long-term effects of repeated metabolic stress

These investigations aim to clarify the biochemical pathways that connect diet, metabolism, and chronic disease.

Other Interesting Links

Use these pages to move between fructose metabolism, ATP depletion, high uric acid, gout risk, blood pressure, kidney disease, and the wider metabolic syndrome pattern.

[ Uric Acid Biochemistry Purines, ATP depletion, urate, and fructose metabolism. ](https://www.internets.com/fructose-science-uric-acid-biochemistry/) [ Uric Acid as a Warning Signal How rising uric acid reflects metabolic overload. ](https://www.internets.com/metabolic-disease-uric-acid/) [ Hyperuricemia High uric acid in gout, kidneys, and metabolic syndrome. ](https://www.internets.com/metabolic-disease-hyperuricemia/) [ What Causes High Uric Acid? A plain-language entry point for readers. ](https://www.internets.com/what-causes-high-uric-acid/) [ ATP Depletion The energy-stress step that feeds uric acid production. ](https://www.internets.com/fructose-science-atp-depletion/) [ Hypertension Blood pressure as part of the same metabolic pattern. ](https://www.internets.com/metabolic-disease-hypertension/) [ Kidney Disease Where uric acid, blood pressure, and filtration intersect. ](https://www.internets.com/metabolic-disease-renal-failure/) [ Insulin Resistance The broader regulatory failure behind the pathway. ](https://www.internets.com/fructose-science-insulin-resistance/)
### Insulin Signaling and Glucose Regulation
URL: https://www.internets.com/fructose-science-insulin-signaling/
Last updated: 2026-08-03T14:30:25.000Z
Subsection Navigation  

Core and Overview: [Overview](https://www.internets.com/fructose-science/) • [Metabolic Syndrome Biochemistry](https://www.internets.com/fructose-science-metabolic-syndrome-biochemistry/) • [Fructose Evolution / Thrifty Pathway](https://www.internets.com/fructose-science-fructose-evolution-thrifty-pathway/)  | Fructose Pathway: [Fructose vs Glucose](https://www.internets.com/fructose-science-fructose-vs-glucose/) • [GLUT5](https://www.internets.com/fructose-science-glut5/) • [KHK](https://www.internets.com/fructose-science-khk/) • [Fructose Metabolism](https://www.internets.com/fructose-science-fructose-metabolism/) • [Liver Metabolic Gate](https://www.internets.com/fructose-science-liver-metabolic-gate/) • [ATP Depletion](https://www.internets.com/fructose-science-atp-depletion/) • [Uric Acid Biochemistry](https://www.internets.com/fructose-science-uric-acid-biochemistry/) • [De Novo Lipogenesis](https://www.internets.com/fructose-science-de-novo-lipogenesis/) • [HFCS](https://www.internets.com/fructose-science-hfcs/) • [ALT](https://www.internets.com/fructose-science-what-is-alt-alanine-aminotransferase/)  | Hormones and Regulation: [Insulin Signaling](https://www.internets.com/fructose-science-insulin-signaling/) • [Insulin Resistance](https://www.internets.com/fructose-science-insulin-resistance/) • [Adipokines & Hormones](https://www.internets.com/fructose-science-adipokines-hormones/) • [Leptin](https://www.internets.com/fructose-science-leptin/) • [Ghrelin](https://www.internets.com/fructose-science-ghrelin/) • [Asprosin](https://www.internets.com/fructose-science-asprosin/) • [Adiponectin](https://www.internets.com/fructose-science-adiponectin-metabolic-protection/) 

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-12.43.37---PM.png)

Glucose is one of the body’s primary sources of energy. Maintaining stable blood glucose levels is essential for normal cellular function, particularly in the brain and nervous system.

The hormone insulin plays a central role in regulating glucose metabolism. Produced by specialized cells in the pancreas, insulin coordinates how tissues absorb, store, and use glucose after meals.

When insulin signaling functions properly, blood glucose levels remain within a relatively narrow physiological range. When this system becomes disrupted, however, glucose regulation may deteriorate, contributing to insulin resistance and eventually type 2 diabetes.

Understanding how insulin signaling works is therefore fundamental to understanding metabolic disease.

**The Pancreas and Insulin Secretion**

Insulin is produced by beta cells located in clusters of endocrine tissue within the pancreas known as the islets of Langerhans.

After a meal, rising blood glucose levels stimulate these beta cells to release insulin into the bloodstream. The hormone then circulates throughout the body and interacts with insulin receptors on the surface of many different cell types.

Insulin secretion occurs in a carefully regulated pattern that allows the body to respond rapidly to changing nutrient conditions.

**Insulin Receptors and Cellular Signaling**

When insulin reaches a target cell, it binds to an insulin receptor embedded in the cell membrane.

This binding activates a complex signaling cascade inside the cell. Through a series of phosphorylation events and intracellular signaling pathways, the insulin receptor communicates instructions that influence how the cell handles nutrients.

These signals affect multiple metabolic processes, including:

• glucose transport into cells

• glycogen synthesis

• lipid metabolism

• protein synthesis

• suppression of glucose production by the liver

Through these mechanisms, insulin helps coordinate energy storage and utilization throughout the body.

**Glucose Uptake in Muscle and Fat**

Two of the most important tissues affected by insulin signaling are skeletal muscle and adipose tissue.

In these tissues, insulin stimulates the movement of glucose transporter proteins—particularly GLUT4—to the cell surface. These transporters allow glucose molecules to enter the cell.

Once inside the cell, glucose can be used to produce energy or stored as glycogen.

Because skeletal muscle represents a large proportion of body mass, insulin-mediated glucose uptake by muscle plays a major role in controlling blood glucose levels.

**Insulin and the Liver**

The liver also responds to insulin signaling, but in a different way.

Rather than absorbing large quantities of glucose directly, the liver regulates glucose levels by adjusting its own production and release of glucose into the bloodstream.

Under normal conditions, insulin suppresses the liver’s production of glucose between meals. This prevents unnecessary increases in blood sugar.

When insulin signaling is impaired, however, the liver may continue producing glucose even when blood glucose levels are already elevated.

This inappropriate glucose production is a major contributor to hyperglycemia in type 2 diabetes.

**Insulin Resistance**

When tissues become less responsive to insulin signals, the condition is known as insulin resistance.

In insulin-resistant states, cells require higher concentrations of insulin to achieve the same metabolic effect. The pancreas often compensates by producing more insulin in order to maintain normal glucose levels.

Over time, this compensatory mechanism may become insufficient. Blood glucose levels then begin to rise, leading to prediabetes and eventually type 2 diabetes.

Insulin resistance is strongly associated with several metabolic factors, including:

• visceral adiposity

• fatty liver disease

• chronic inflammation

• excess caloric intake

• sedentary lifestyle

**Metabolic Integration**

Insulin signaling does not function in isolation. It interacts with many other metabolic systems within the body.

For example:

• adipose tissue releases signaling molecules that influence insulin sensitivity

• liver metabolism affects glucose production and lipid synthesis

• muscle activity influences glucose uptake

• inflammatory pathways can disrupt insulin signaling

These interactions illustrate why metabolic disease is best understood as a systemic disorder involving multiple organs.

**Clinical Importance**

Impaired insulin signaling lies at the heart of several common metabolic disorders.

Conditions strongly associated with insulin resistance include:

• type 2 diabetes

• metabolic syndrome

• fatty liver disease

• cardiovascular disease

Because of this central role, many preventive strategies for metabolic disease focus on improving insulin sensitivity through lifestyle changes and medical management when appropriate.

**Related Topics**

Readers interested in the metabolic processes discussed on this page may also explore:

**• Insulin Resistance**

**• Metabolic Syndrome**

**• Fatty Liver Disease (MASLD)**

**• Visceral Fat and Metabolic Health**

These pages examine the broader physiological context of insulin signaling and glucose metabolism.
### The Portal Circulation
URL: https://www.internets.com/fructose-science-portal-vein/
Last updated: 2026-04-13T11:36:39.000Z
## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-04-at-10.05.07---PM.png)

One of the most important anatomical features of human metabolism is the portal circulation, the vascular system that carries nutrients from the digestive tract directly to the liver.

After food is digested and absorbed in the intestine, nutrients do not immediately enter the general bloodstream. Instead, most carbohydrates, amino acids, and other absorbed molecules are transported first to the liver through a specialized vessel known as the portal vein.

Because of this arrangement, the liver acts as the body’s primary metabolic checkpoint. It determines how nutrients are processed, stored, or redistributed before they reach the rest of the body.

This function has led some researchers to describe the liver as a metabolic gate between the intestine and systemic circulation.

**The Portal Circulation**

The portal vein collects blood from several organs involved in digestion, including:

• the small intestine

• the stomach

• the pancreas

• the spleen

This blood is rich in nutrients that have just been absorbed from food.

Rather than traveling directly to the heart, portal blood flows first to the liver. Within the liver it enters a network of specialized capillaries known as hepatic sinusoids, where hepatocytes are exposed to the absorbed nutrients.

This unique circulatory pathway allows the liver to regulate metabolic processing before nutrients are distributed throughout the body.

**Nutrient Processing in the Liver**

Once portal blood enters the liver, hepatocytes begin processing the nutrients delivered from the intestine.

The liver can perform several functions at this stage:

• converting glucose to glycogen for storage

• synthesizing fatty acids from excess carbohydrate

• producing lipoproteins that transport lipids in the bloodstream

• converting amino acids into metabolic intermediates

• detoxifying compounds absorbed from food

These processes allow the liver to buffer sudden changes in nutrient intake and maintain metabolic stability.

**Carbohydrates and the Portal Vein**

Carbohydrates absorbed from the intestine are transported through the portal vein primarily in the form of glucose and fructose.

Glucose can be used directly by many tissues throughout the body, but fructose metabolism occurs largely within the liver.

Because the portal vein delivers fructose to the liver in high concentrations shortly after meals, hepatic metabolism plays a particularly important role in processing this sugar.

This pathway explains why many metabolic studies examining fructose metabolism focus on hepatic biochemical processes.

**Portal Circulation and Metabolic Disease**

Because the portal vein delivers nutrients directly from the intestine to the liver, the liver is exposed to high concentrations of dietary substrates.

Under conditions of chronic caloric excess or high intake of refined carbohydrates, the liver may experience sustained metabolic stress.

This stress can contribute to several metabolic disturbances, including:

• increased lipid synthesis

• accumulation of fat within hepatocytes

• altered glucose regulation

• increased production of circulating lipoproteins

Over time these changes may play a role in the development of fatty liver disease, insulin resistance, and metabolic syndrome.

**The Liver’s Strategic Position**

The portal circulation places the liver at a strategic intersection between digestion and systemic metabolism.

By controlling how nutrients are processed before they enter the broader circulation, the liver exerts powerful influence over the body’s metabolic environment.

This central role explains why disturbances in hepatic metabolism can affect multiple organs, including the pancreas, adipose tissue, and cardiovascular system.

Understanding the portal circulation therefore provides important insight into the broader physiology of metabolic disease.

**Related Topics**

Readers interested in the metabolic processes discussed on this page may also explore:

**•** [**The Liver as Metabolic Gate**](https://www.internets.com/fructose-science-liver-metaolic-gate)

**•** [**De Novo Lipogenesis**](https://www.internets.com/liver-metabolism/lipogenesis)

**•** [**Fatty Liver Disease**](https://www.internets.com/liver-metabolism/fatty-liver) **(MASLD)**

**•** [**The Cardio-Hepatic Axis**](https://www.internets.com/cardiometabolic/cardio-hepatic-axis)

These topics examine the downstream metabolic consequences of hepatic nutrient processing.
### Inflammation and Metabolic Disease
URL: https://www.internets.com/metabolic-disease-inflammation/
Last updated: 2026-04-26T22:19:40.000Z
Subsection Navigation 

Core Pages: [Fructose Disease Arc](https://www.internets.com/metabolic-disease-fructose-disease-arc/) • [Metabolic Disease](https://www.internets.com/metabolic-disease/) • [Metabolic Syndrome (Biochemistry)](https://www.internets.com/metabolic-disease-metabolic-syndrome-biochemistry/) • [Metabolic Syndrome (Clinical)](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)  | Body Fat and Metabolic Drivers: [Visceral Adiposity & Inflammatory Signaling](https://www.internets.com/metabolic-disease-visceral-adiposity-and-inflammatory-signaling/) • [Cardio-Hepatic Axis](https://www.internets.com/metabolic-disease-cardio-hepatic-axis/) • [Inflammation](https://www.internets.com/metabolic-disease-inflammation/)  | Lipid and Metabolic Risk: [Cholesterol](https://www.internets.com/metabolic-disease-what-is-cholesterol/) • [Triglycerides](https://www.internets.com/metabolic-disease-triglycerides-cardiovascular-risk/) • [LDL](https://www.internets.com/metabolic-disease-small-dense-ldl/) • [HDL](https://www.internets.com/metabolic-disease-hdl-cholesterol/)  | Clinical Disease Expression: [Dyslipidemia](https://www.internets.com/metabolic-disease-dyslipidemia/) • [Obesity](https://www.internets.com/metabolic-disease-obesity/) • [Fatty Liver](https://www.internets.com/metabolic-disease-masld/) • [Prediabetes](https://www.internets.com/metabolic-disease-prediabetes/) • [Type 2 Diabetes](https://www.internets.com/metabolic-disease-type-2-diabetes/) • [Hypertension](https://www.internets.com/metabolic-disease-hypertension/) • [Cardiovascular Disease](https://www.internets.com/metabolic-disease-cardiovascular-disease/) • [Sleep Apnea](https://www.internets.com/metabolic-disease-sleep-apnea/) • [HFpEF](https://www.internets.com/metabolic-disease-hfpef/) • [Hyperuricemia](https://www.internets.com/metabolic-disease-hyperuricemia/) • [Renal Failure](https://www.internets.com/metabolic-disease-renal-failure/) • [Gut Microbiome](https://www.internets.com/metabolic-disease-gut-microbiome-metabolism/) • [Renin-Angiotensin System](https://www.internets.com/renin/)  | Special Topics: [Dementia](https://www.internets.com/metabolic-disease-dementia/) • [Fructose & Cancer Metabolism](https://www.internets.com/fructose-science-fructose-cancer-metabolism/) • [Warburg Effect](https://www.internets.com/metabolic-disease-fructose-warburg-effect/)  | Reversal and Recovery: [Reversal with Diet](https://www.internets.com/metabolic-disease-reversal/) • [Reversal with Drugs](https://www.internets.com/clinical-resources-reversal-with-drugs-md/) 

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-11.17.48---AM.png)

Inflammation is a fundamental biological process that helps the body respond to injury and infection. When tissues are damaged or exposed to harmful stimuli, the immune system activates a series of protective responses designed to eliminate threats and promote healing.

In metabolic disease, however, a different form of inflammation often develops. Instead of the intense, short-lived inflammation seen during infection or injury, metabolic disorders are frequently associated with chronic low-grade inflammation.

This persistent inflammatory signaling can influence metabolic pathways throughout the body and is increasingly recognized as an important component of metabolic syndrome, fatty liver disease, insulin resistance, and cardiovascular disease.

## **Acute vs. Chronic Inflammation**

Inflammation occurs in several forms.

Acute inflammation is a rapid and short-term immune response that occurs when the body encounters infection, injury, or other immediate threats. This process involves immune cell activation, increased blood flow to affected tissues, and the release of signaling molecules that help repair damaged tissue.

Chronic inflammation, by contrast, develops slowly and can persist for long periods of time. Rather than protecting the body from an immediate threat, chronic inflammation often reflects ongoing metabolic stress or tissue dysfunction.

In metabolic disease, this chronic inflammatory state may influence several biological systems simultaneously.

## **Adipose Tissue and Inflammatory Signaling**

Adipose tissue plays an important role in metabolic inflammation.

As adipose tissue expands—particularly visceral fat within the abdominal cavity—immune cells begin to accumulate within the fat tissue. These immune cells release inflammatory signaling molecules known as cytokines.

Examples of these molecules include:

• tumor necrosis factor (TNF)

• interleukin-6 (IL-6)

• other inflammatory mediators

These signals can interfere with insulin signaling pathways and contribute to the development of insulin resistance.

Because visceral adipose tissue produces particularly strong inflammatory signals, abdominal obesity is closely linked with metabolic inflammation.

## **The Liver and Inflammatory Pathways**

The liver also participates in inflammatory regulation.

When metabolic stress develops—such as the accumulation of fat within hepatocytes—the liver may produce inflammatory proteins that circulate through the bloodstream.

One example is C-reactive protein (CRP), an acute-phase protein often measured in clinical settings as a marker of systemic inflammation.

Inflammatory processes within the liver can also influence lipid metabolism, glucose regulation, and vascular signaling.

Because of these effects, liver inflammation may contribute to broader cardiometabolic risk.

## **Inflammation and Insulin Resistance**

Chronic inflammatory signaling can disrupt insulin signaling pathways within several tissues.

Cytokines produced by adipose tissue and immune cells may interfere with intracellular signaling cascades that normally allow cells to respond to insulin. When these pathways are disrupted, tissues become less sensitive to insulin’s metabolic effects.

This process contributes to insulin resistance, a key component of metabolic syndrome and type 2 diabetes.

As insulin resistance develops, the pancreas compensates by producing more insulin. Over time, this compensation may become insufficient, leading to elevated blood glucose levels.

## **Inflammation and Cardiovascular Disease**

Inflammation also plays an important role in cardiovascular disease.

Inflammatory signaling can affect the endothelium, the thin layer of cells that lines blood vessels. Endothelial dysfunction may impair normal vascular regulation and promote the development of atherosclerotic plaque.

Within arterial walls, inflammatory processes can accelerate plaque formation and increase the likelihood that plaques will rupture. When rupture occurs, blood clots may form and obstruct blood flow, leading to heart attacks or strokes.

For this reason, chronic inflammation is now considered an important contributor to cardiovascular risk.

## **A Systemic Process**

Metabolic inflammation illustrates how multiple organs interact during metabolic disease.

Adipose tissue, the liver, the vascular system, and immune signaling pathways form a network of metabolic communication. When this network becomes disrupted by metabolic overload, inflammatory signals may propagate throughout the body.

This systemic perspective helps explain why metabolic disorders often affect multiple organs simultaneously.

## **Research and Therapeutic Implications**

Research into metabolic inflammation continues to expand. Scientists are investigating how dietary patterns, physical activity, and metabolic signaling pathways influence inflammatory responses.

Some therapies aimed at improving metabolic health may also reduce inflammatory signaling. Lifestyle interventions that improve insulin sensitivity and reduce visceral adiposity often lower markers of systemic inflammation.

Understanding the biological relationship between metabolism and inflammation may therefore provide new opportunities for preventing and treating metabolic disease.

## **Related Topics**

Readers interested in the metabolic pathways discussed on this page may also explore:

**• Visceral Fat and Metabolic Health**

**• Insulin Resistance**

**• Fatty Liver Disease (MASLD)**

**• Metabolic Syndrome and Cardiovascular Disease**

These pages examine additional aspects of the metabolic processes associated with chronic inflammation.
### The Modern Processed Foods
URL: https://www.internets.com/food-the-modern-diet/
Last updated: 2026-08-21T22:28:38.000Z
**Key takeaways.** Ultra-processed foods are industrial formulations defined principally by how they are made and formulated, not by a single nutrient. Processing is a spectrum: freezing vegetables, fermenting foods and canning beans are not equivalent to manufacturing energy-dense ready-to-eat formulations.

## What the Strongest Experimental Evidence Shows

In a randomized inpatient crossover trial, 20 adults were offered an ultra-processed diet and an unprocessed diet for two weeks each. The meals were designed to match several presented nutrients, yet participants consumed about 508 additional kilocalories per day during the ultra-processed phase. They gained approximately 0.9 kg during that phase and lost approximately 0.9 kg during the unprocessed phase. The study demonstrates a causal effect in a controlled setting, but it does not establish that every ultra-processed product produces the same response.

## What Observational Evidence Adds

A 2024 umbrella review synthesized 45 pooled analyses involving nearly 10 million participants. Greater ultra-processed-food exposure was associated with numerous adverse outcomes, including type 2 diabetes, obesity and cardiovascular mortality. Evidence certainty varied from moderate to very low, and most included evidence was observational; associations should therefore not be presented as proof that processing alone caused every outcome.

## Processing Is Not the Only Question

A complete assessment also considers food structure, nutrient profile, portion size, affordability and cultural role. Some packaged foods can provide safety, convenience or fortification. The practical priority is to prevent highly processed products from displacing vegetables, fruit, legumes, intact grains, nuts, root crops and appropriate protein foods.

## Selected Authoritative Sources

- [Hall KD et al. Ultra-processed diets cause excess calorie intake and weight gain.](https://pubmed.ncbi.nlm.nih.gov/31105044/?ref=internets.com)
- [Lane MM et al. Ultra-processed food exposure and adverse health outcomes: umbrella review.](https://pubmed.ncbi.nlm.nih.gov/38418082/?ref=internets.com)
- [World Health Organization: Healthy diet](https://www.who.int/news-room/fact-sheets/detail/healthy-diet?ref=internets.com)
- [FAO: Food-based dietary guidelines—Brazil](https://www.fao.org/nutrition/education/food-dietary-guidelines/regions/countries/brazil/en/?ref=internets.com)

---

## Food Subsection Navigation

[**Food**](https://www.internets.com/food/) • [**Evolution and Diet**](https://www.internets.com/food-evolution-and-diet/) • [**Ancestral Foods**](https://www.internets.com/food-ancestral-foods/) • [**Modern Diet**](https://www.internets.com/food-the-modern-diet/) • [**NOVA and Ultra-Processed Foods**](https://www.internets.com/food-nova/) • [**Sugar History**](https://www.internets.com/food-history-of-sugar-pre-1984/) • [**Sugary Drinks**](https://www.internets.com/food-sugary-drinks/) • [**Starches**](https://www.internets.com/food-safe-starches/) • [**Rice**](https://www.internets.com/food-rice/) • [**Bread**](https://www.internets.com/food-bread/) • [**Root Crops**](https://www.internets.com/food-root-crops/) • [**Legumes**](https://www.internets.com/food-legumes/) • [**Nuts**](https://www.internets.com/food-safe-nuts/) • [**Genes and Food**](https://www.internets.com/food-genes-and-food/) • [**Dietary Guidelines**](https://www.internets.com/food-usda-dietary-guidelines/)

## **Introduction: Food Processing**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-25-at-4.17.53---PM.png)

Food processing has long played a role in human nutrition. Techniques such as drying, fermenting, cooking, and preserving allowed earlier societies to store food and improve its safety.

In recent decades, however, a new category of foods has become increasingly prominent in many diets: ultra-processed foods.

Ultra-processed foods are industrial formulations created primarily from refined ingredients, additives, and manufactured components rather than whole foods. These products are typically designed for convenience, long shelf life, and highly consistent flavor and texture.

The growing consumption of ultra-processed foods has coincided with the global rise of metabolic diseases such as obesity, type 2 diabetes, and fatty liver disease. For this reason, researchers have begun examining how modern food systems influence metabolic health.

## **What Are Ultra-Processed Foods?**

Nutrition researchers often classify foods according to the degree of industrial processing they undergo.

Ultra-processed foods are typically characterized by:

• ingredients derived from refined starches, sugars, or oils

• food additives such as flavor enhancers, emulsifiers, and stabilizers

• extensive industrial manufacturing processes

• minimal intact whole-food ingredients

Examples may include:

• sweetened beverages

• packaged snack foods

• confectionery and desserts

• many ready-to-eat meals

• certain processed meat products

These foods often contain combinations of refined carbohydrates, added sugars, and fats that are uncommon in traditional dietary patterns.

## **Energy Density and Palatability**

Ultra-processed foods are frequently designed to be highly palatable. Through careful combinations of sweetness, saltiness, and fat content, these foods may stimulate reward pathways that encourage repeated consumption.

Many ultra-processed foods are also energy dense, meaning they contain a large number of calories relative to their weight or volume.

Because these products are easy to consume quickly and require little preparation, they may contribute to increased caloric intake in some individuals.

## **Refined Carbohydrates and Added Sugars**

Another common feature of ultra-processed foods is the use of refined carbohydrates and added sugars.

Industrial processing often removes fiber and structural components from whole grains or other plant foods. The resulting refined ingredients can be rapidly digested and absorbed.

Added sugars—including sucrose and high-fructose corn syrup—are frequently used to enhance flavor and preserve products. These sugars contribute to total carbohydrate intake and influence metabolic pathways discussed elsewhere on this site, including fructose metabolism and lipid synthesis in the liver.

## **Dietary Patterns and Metabolic Health**

Large observational studies have found associations between high consumption of ultra-processed foods and increased rates of obesity, metabolic syndrome, and other metabolic disorders.

Several factors may contribute to these relationships:

• increased caloric intake

• altered nutrient composition

• reduced dietary fiber

• rapid absorption of refined carbohydrates

• changes in satiety signaling

Because these factors often occur together, it can be difficult to isolate the effects of individual ingredients.

Nevertheless, many researchers believe that the overall structure of modern food environments plays an important role in metabolic health.

## **Decline of Traditional Dietary Patterns**

The rise of ultra-processed foods has occurred alongside major changes in global food systems.

Urbanization, globalization of agriculture, and industrial food manufacturing have made packaged foods widely available in both developed and developing countries. At the same time, traditional dietary patterns based on minimally processed foods have declined in many regions.

This transition has occurred rapidly compared with the pace of human biological adaptation.

Understanding how these changes interact with human metabolism is a central theme of research into the modern metabolic crisis.

## **A Systems Perspective**

Ultra-processed foods illustrate how the food environment can influence metabolic physiology.

The biological mechanisms discussed throughout this site—such as insulin signaling, hepatic lipid synthesis, and inflammatory pathways—do not operate independently of diet. Instead, they respond continuously to patterns of nutrient exposure.

When dietary patterns shift dramatically, metabolic systems must adapt to new conditions.

Examining both the biological pathways and the environmental factors influencing them provides a more complete understanding of modern metabolic disease.

## **Related Topics**

Readers interested in exploring these ideas further may also consult:

**•** [**Fructose Metabolism**](https://www.internets.com/fructose-science-fructose)

**•** [**GLUT-5**](https://www.internets.com/fructose-scoience-glut5)

**•** [**Metabolic Syndrome**](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)

**•** [**Metabolic Inflammation**](https://www.internets.com/metabolic-disease-inflammation)[](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)

**•** [**Dangerous Starches**](https://www.internets.com/food-dangerous-starches/)[](https://www.internets.com/metabolic-disease-metabolic-syndrome-clinical/)

**•** [**Safe Starches**](https://www.internets.com/food-safe-starches)

These pages examine the biological and environmental factors that interact in modern metabolic disease.
### High-Fructose Corn Syrup and Industrial Sweeteners
URL: https://www.internets.com/fructose-science-hfcs/
Last updated: 2026-06-05T14:33:03.000Z
Subsection Navigation  

Core and Overview: [Overview](https://www.internets.com/fructose-science/) • [Metabolic Syndrome Biochemistry](https://www.internets.com/fructose-science-metabolic-syndrome-biochemistry/) • [Fructose Evolution / Thrifty Pathway](https://www.internets.com/fructose-science-fructose-evolution-thrifty-pathway/)  | Fructose Pathway: [Fructose vs Glucose](https://www.internets.com/fructose-science-fructose-vs-glucose/) • [GLUT5](https://www.internets.com/fructose-science-glut5/) • [KHK](https://www.internets.com/fructose-science-khk/) • [Fructose Metabolism](https://www.internets.com/fructose-science-fructose-metabolism/) • [Liver Metabolic Gate](https://www.internets.com/fructose-science-liver-metabolic-gate/) • [ATP Depletion](https://www.internets.com/fructose-science-atp-depletion/) • [Uric Acid Biochemistry](https://www.internets.com/fructose-science-uric-acid-biochemistry/) • [De Novo Lipogenesis](https://www.internets.com/fructose-science-de-novo-lipogenesis/) • [HFCS](https://www.internets.com/fructose-science-hfcs/) • [ALT](https://www.internets.com/fructose-science-what-is-alt-alanine-aminotransferase/)  | Hormones and Regulation: [Insulin Signaling](https://www.internets.com/fructose-science-insulin-signaling/) • [Insulin Resistance](https://www.internets.com/fructose-science-insulin-resistance/) • [Adipokines & Hormones](https://www.internets.com/fructose-science-adipokines-hormones/) • [Leptin](https://www.internets.com/fructose-science-leptin/) • [Ghrelin](https://www.internets.com/fructose-science-ghrelin/) • [Asprosin](https://www.internets.com/fructose-science-asprosin/) • [Adiponectin](https://www.internets.com/fructose-science-adiponectin-metabolic-protection/) 

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-04-at-9.42.33---PM.png)

Modern food systems rely on a variety of sweetening agents to enhance flavor, preserve products, and improve texture. Among these sweeteners, high-fructose corn syrup (HFCS) has become one of the most widely used ingredients in many processed foods and beverages.

High-fructose corn syrup is produced through industrial processing of corn starch and is commonly used in soft drinks, packaged desserts, sauces, and many other manufactured foods. Its use expanded rapidly during the late twentieth century as food manufacturers adopted new sweetening technologies.

Understanding how HFCS is produced and how it compares with traditional sugars helps clarify its role in modern dietary patterns.

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-27-at-9.44.36---AM.png)

## **From Corn Starch to Sweetener**

High-fructose corn syrup is derived from corn starch, a carbohydrate composed of long chains of glucose molecules.

The manufacturing process typically involves several enzymatic steps:

1. Corn starch is first broken down into glucose molecules.
2. Some of this glucose is then converted into fructose using specialized enzymes.
3. The resulting mixture of glucose and fructose is adjusted to achieve the desired sweetness level.

Different formulations of HFCS contain varying proportions of fructose and glucose. One common form used in beverages contains approximately 55 percent fructose and 45 percent glucose, while another widely used formulation contains about 42 percent fructose.

## **Comparison with Sucrose**

HFCS is often compared with sucrose, the common table sugar produced from sugarcane or sugar beets.

Sucrose is composed of one molecule of glucose bound to one molecule of fructose. During digestion, the bond between these molecules is broken, releasing free glucose and fructose.

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/06/Screenshot-2026-06-05-at-10.26.33---AM.png)

Source: The Sweet Killer, 2nd edition, 2026

## **Industrial Advantages**

High-fructose corn syrup gained widespread adoption in the food industry for several practical reasons.

These include:

• relatively low production cost

• ease of transport and storage in liquid form

• stability in beverages and processed foods

• consistent sweetness and flavor

Because HFCS is easily incorporated into liquid products, it became particularly common in soft drinks and sweetened beverages.

The growth of the beverage industry played a major role in the expansion of HFCS consumption during the late twentieth century.

## **Sweetened Beverages and Sugar Intake**

Sweetened beverages represent one of the largest sources of added sugars in many modern diets.

Unlike solid foods, beverages can be consumed quickly and in large quantities without producing the same level of satiety. This characteristic may contribute to increased total caloric intake in some individuals.

Beverages sweetened with HFCS or sucrose often deliver substantial amounts of rapidly absorbed sugars. These sugars enter metabolic pathways discussed elsewhere on this site, including hepatic fructose metabolism and lipid synthesis.

Because of these properties, sweetened beverages have become a focus of research examining the dietary factors associated with metabolic disease.

## **Global Variation**

Patterns of sweetener use vary across different regions of the world.

In the United States, HFCS has historically been widely used in many processed foods and beverages. In other regions, sucrose remains the dominant added sugar.

Despite these differences, total added sugar consumption remains an important factor in dietary patterns worldwide.

As food manufacturing and distribution systems expand globally, the availability of sweetened products continues to increase in many countries.

## **Research Perspectives**

Scientific research examining added sugars and metabolic health continues to evolve. Researchers study how different types of sugars interact with metabolic pathways related to insulin signaling, lipid synthesis, and energy regulation.

Many studies emphasize the importance of overall dietary patterns, including total caloric intake, nutrient composition, and the degree of food processing.

Understanding how industrial sweeteners are incorporated into modern diets helps provide context for the biological mechanisms explored in other sections of this site.

## **Related Topics**

Readers interested in the metabolic pathways influenced by dietary sugars may also explore:

**• Fructose Metabolism**

**• De Novo Lipogenesis**

**• Ultra-Processed Foods and the Modern Diet**

**• Sugar Consumption and the Global Dietary Transition**
### The Western Diet and the Metabolic Environment
URL: https://www.internets.com/food-western-diet-and-environment/
Last updated: 2026-08-21T11:02:06.000Z
---

## Food Subsection Navigation

[**Food**](https://www.internets.com/food/) • [**Evolution and Diet**](https://www.internets.com/food-evolution-and-diet/) • [**Ancestral Foods**](https://www.internets.com/food-ancestral-foods/) • [**Modern Diet**](https://www.internets.com/food-the-modern-diet/) • [**NOVA and Ultra-Processed Foods**](https://www.internets.com/food-nova/) • [**Sugar History**](https://www.internets.com/food-history-of-sugar-pre-1984/) • [**Sugary Drinks**](https://www.internets.com/food-sugary-drinks/) • [**Starches**](https://www.internets.com/food-safe-starches/) • [**Rice**](https://www.internets.com/food-rice/) • [**Bread**](https://www.internets.com/food-bread/) • [**Root Crops**](https://www.internets.com/food-root-crops/) • [**Legumes**](https://www.internets.com/food-legumes/) • [**Nuts**](https://www.internets.com/food-safe-nuts/) • [**Genes and Food**](https://www.internets.com/food-genes-and-food/) • [**Dietary Guidelines**](https://www.internets.com/food-usda-dietary-guidelines/)

## **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-9.52.47---AM.png)

The term Western diet is commonly used to describe a pattern of eating that developed in industrialized nations during the twentieth century and has since spread to many parts of the world. Since the "Western" diet bears very little resemblance to the original nutritious diets of Western Europe, Internets Press prefers to label this diet as the "Modern" diet.

Although specific foods vary across regions, the Modern dietary pattern is typically characterized by high consumption of refined carbohydrates, added sugars, industrially processed foods, and energy-dense products. At the same time, intake of whole foods such as vegetables, fruits, legumes, and minimally processed grains is often lower than in many traditional dietary patterns.

Researchers studying global nutrition have increasingly examined how this dietary shift may influence metabolic health.

## **Characteristics of the Modern Diet**

Several common features distinguish the Modern diet from many traditional dietary patterns.

These include:

• high intake of refined grains

• frequent consumption of added sugars

• increased availability of sweetened beverages

• higher consumption of processed and ultra-processed foods

• increased intake of industrial vegetable oils and refined fats

• lower intake of dietary fiber and whole foods

These elements often appear together in modern food environments and may influence metabolic physiology through multiple pathways.

## **Dietary Energy and Metabolic Load**

The Modern diet frequently contains foods that are both energy dense and highly palatable. These characteristics may encourage greater caloric intake compared with diets composed primarily of minimally processed foods.

When caloric intake repeatedly exceeds energy expenditure, the body must store excess nutrients. Over time this process can contribute to increased adiposity, particularly visceral fat accumulation.

As discussed elsewhere on this site, excess adiposity and metabolic overload are closely associated with insulin resistance, fatty liver disease, and metabolic syndrome.

 Key Takeaways

- The modern industrial food environment makes refined, energy-dense products convenient, inexpensive and heavily marketed, while healthier foods may be less accessible.
- Processing is not automatically harmful. The important distinctions include the food’s structure, ingredients, nutrient profile, preparation and role in the overall dietary pattern.
- In a controlled NIH feeding trial, participants ate about 500 additional kilocalories per day and gained weight during an ultra-processed diet compared with a minimally processed diet, despite meals being designed to match several presented nutrients.
- Individual advice matters, but population health also depends on school food, marketing, pricing, product formulation and access to minimally processed foods.

## What Is the Modern Food Environment?

A **food environment** is the physical, economic, commercial and social setting in which people obtain and consume food. It includes supermarkets, restaurants, schools, workplaces, advertising, delivery platforms, prices, portion sizes and the time available for cooking. The term explains why diet is not determined by willpower alone.

The modern dietary pattern is global rather than uniquely Western. Its foods vary by country, but common features include refined grains, sugary drinks, packaged snacks, rapidly prepared meals and products engineered for convenience and long shelf life. Traditional foods can remain central while these products become increasingly frequent additions.

## Processing, Food Structure and Energy Intake

Food processing ranges from washing, freezing and fermentation to extrusion, fractionation and the manufacture of ready-to-eat formulations. Freezing vegetables, fermenting yogurt or cooking beans can improve safety and usefulness. The concern is not processing in the abstract, but dietary patterns dominated by products that are easy to eat quickly, energy dense and commonly high in free sugars, sodium or unhealthy fats.

In a randomized inpatient crossover trial involving 20 adults, Hall and colleagues found that an ultra-processed diet produced an average increase of approximately 508 kilocalories per day compared with an unprocessed diet. Participants gained about 0.9 kg during two weeks on the ultra-processed diet and lost about 0.9 kg during the unprocessed phase. This short trial demonstrated a causal effect under controlled conditions, but it did not establish that every ultra-processed product has the same effect or predict an individual’s long-term outcome.

## Metabolic Pathways

A modern dietary pattern can affect health through several overlapping pathways. Rapidly digestible carbohydrates can increase post-meal glucose demand; sugary beverages deliver free sugars without the intact fibre and chewing of whole fruit; high energy density and rapid eating can weaken satiation; and excess energy can promote visceral and liver fat accumulation. Sodium, alcohol, sleep, physical activity, medicines, genetics and socioeconomic conditions also influence blood pressure, diabetes and liver disease.

Metabolic syndrome is not caused by one food. It describes a cluster that can include central adiposity, elevated blood pressure, abnormal glucose regulation, high triglycerides and low HDL cholesterol. The value of the concept is that these risks often occur together and merit earlier assessment.

## Marketing, Affordability and Health Equity

Commercial exposure is uneven. Children and lower-income communities may encounter more promotion of inexpensive sugary drinks, snacks and fast food while facing higher prices, limited transport or less time for food preparation. Advice that ignores these constraints can become both ineffective and unfair.

Useful responses include reliable drinking water, healthier school and workplace food, clear labels, restrictions on harmful marketing to children, reformulation, appropriate fiscal policies and support for farmers, markets and retailers that supply vegetables, fruit, legumes, whole grains and other minimally processed foods.

## What a Healthier Pattern Looks Like

The World Health Organization describes healthy diets through four principles: adequacy, balance, moderation and diversity. In practical terms, meals can be built around vegetables, fruit, pulses, nuts, whole grains and appropriate sources of protein, with free sugars, excess sodium, industrial trans fat and heavily processed foods limited. Cultural food traditions provide many ways to meet these principles; there is no single universal menu.

- Choose water as the routine drink.
- Retain intact structure when possible: whole or minimally milled grains, beans, lentils and root crops rather than refined snack products.
- Use ingredient lists and nutrition labels to compare added sugars, sodium and saturated fat.
- Combine carbohydrate foods with vegetables, legumes or protein and consider portion size.
- Treat occasional foods as occasional rather than assigning moral labels to people or cultures.

## Selected Authoritative Sources

- [World Health Organization: Healthy diet](https://www.who.int/news-room/fact-sheets/detail/healthy-diet?ref=internets.com)
- [Hall KD et al. Ultra-Processed Diets Cause Excess Calorie Intake and Weight Gain. *Cell Metabolism*. 2019.](https://pubmed.ncbi.nlm.nih.gov/31105044/?ref=internets.com)
- [FAO: Food-based dietary guidelines—Brazil](https://www.fao.org/nutrition/education/food-dietary-guidelines/regions/countries/brazil/en/?ref=internets.com)
- [Internets: NOVA, Nutri-Score and international dietary practices](https://www.internets.com/food-nova/)
- [Internets: Sugary drinks](https://www.internets.com/food-sugary-drinks/)
### Fructose, Evolution, and the Thrifty Pathway
URL: https://www.internets.com/fructose-science-fructose-evolution-thrifty-pathway/
Last updated: 2026-08-03T14:30:04.000Z
Subsection Navigation  

Core and Overview: [Overview](https://www.internets.com/fructose-science/) • [Metabolic Syndrome Biochemistry](https://www.internets.com/fructose-science-metabolic-syndrome-biochemistry/) • [Fructose Evolution / Thrifty Pathway](https://www.internets.com/fructose-science-fructose-evolution-thrifty-pathway/)  | Fructose Pathway: [Fructose vs Glucose](https://www.internets.com/fructose-science-fructose-vs-glucose/) • [GLUT5](https://www.internets.com/fructose-science-glut5/) • [KHK](https://www.internets.com/fructose-science-khk/) • [Fructose Metabolism](https://www.internets.com/fructose-science-fructose-metabolism/) • [Liver Metabolic Gate](https://www.internets.com/fructose-science-liver-metabolic-gate/) • [ATP Depletion](https://www.internets.com/fructose-science-atp-depletion/) • [Uric Acid Biochemistry](https://www.internets.com/fructose-science-uric-acid-biochemistry/) • [De Novo Lipogenesis](https://www.internets.com/fructose-science-de-novo-lipogenesis/) • [HFCS](https://www.internets.com/fructose-science-hfcs/) • [ALT](https://www.internets.com/fructose-science-what-is-alt-alanine-aminotransferase/)  | Hormones and Regulation: [Insulin Signaling](https://www.internets.com/fructose-science-insulin-signaling/) • [Insulin Resistance](https://www.internets.com/fructose-science-insulin-resistance/) • [Adipokines & Hormones](https://www.internets.com/fructose-science-adipokines-hormones/) • [Leptin](https://www.internets.com/fructose-science-leptin/) • [Ghrelin](https://www.internets.com/fructose-science-ghrelin/) • [Asprosin](https://www.internets.com/fructose-science-asprosin/) • [Adiponectin](https://www.internets.com/fructose-science-adiponectin-metabolic-protection/) 

**Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-12.06.56---PM.png)

Human metabolism evolved in environments that differed greatly from modern dietary conditions. For much of human history, food availability fluctuated seasonally, and periods of abundance were often followed by periods of scarcity.

Under these circumstances, metabolic pathways that promoted efficient energy storage could improve survival. Some researchers have proposed that certain metabolic responses to fructose and other carbohydrates may have evolved as part of this adaptive strategy.

This idea is sometimes referred to as the thrifty pathway—a set of metabolic mechanisms that help convert excess energy into stored fat when food is plentiful.

Understanding these evolutionary perspectives provides useful context for the metabolic processes discussed elsewhere on this site.

**Seasonal Energy Storage**

In many natural environments, fruits and other carbohydrate-rich foods become available during specific seasons. For animals preparing for periods of reduced food availability, consuming these foods can stimulate metabolic pathways that promote fat storage.

Several physiological responses may occur when large amounts of simple sugars are consumed:

• increased conversion of carbohydrates into fatty acids

• accumulation of triglycerides in adipose tissue

• changes in hormonal signaling that promote energy conservation

These responses allow organisms to store energy that can later be used when food becomes scarce.

Some researchers believe that aspects of human fructose metabolism may reflect similar evolutionary pressures.

**Fructose as a Storage Signal**

Fructose has attracted particular interest in evolutionary metabolism because of its role in certain metabolic pathways associated with energy storage.

Experimental studies suggest that fructose metabolism can influence several biological processes, including:

• stimulation of lipogenesis in the liver

• alterations in cellular energy balance

• increased uric acid production

• metabolic signaling pathways that influence appetite and fat storage

In ancestral environments, these responses may have helped organisms accumulate fat reserves during times of food abundance.

In modern environments where sugar consumption is frequent and continuous, the same pathways may be activated more persistently.

**Uric Acid and Evolution**

Another component of the thrifty pathway hypothesis involves uric acid metabolism.

Humans and certain primates have relatively high circulating uric acid levels compared with many other mammals. This difference is partly related to the loss of an enzyme called uricase, which in other animals breaks down uric acid into more soluble compounds.

Some evolutionary biologists have proposed that this change may have influenced energy metabolism by altering cellular signaling pathways linked to fat storage and metabolic regulation.

Although this hypothesis remains an area of active research, it highlights how evolutionary changes in metabolism may influence modern physiology.

**Evolutionary Mismatch**

The concept of evolutionary mismatch describes situations in which biological systems adapted to past environments encounter very different conditions in modern settings.

Metabolic pathways that once helped organisms survive seasonal food shortages may function differently in environments where energy-dense foods are continuously available.

In modern food systems, refined sugars and sweetened beverages can deliver large quantities of rapidly absorbed carbohydrates throughout the day. This pattern differs from the seasonal and intermittent sugar exposure that characterized many ancestral diets.

Understanding this mismatch helps explain why certain metabolic pathways may respond differently in contemporary dietary environments.

**Scientific Debate**

The thrifty pathway hypothesis remains an area of ongoing scientific discussion. Researchers continue to study how evolutionary pressures shaped metabolic physiology and how those adaptations influence modern health.

Some scientists emphasize the importance of overall caloric intake and lifestyle factors, while others focus on specific metabolic pathways influenced by dietary sugars.

These perspectives are not mutually exclusive. Many aspects of metabolic disease likely arise from interactions among genetics, evolutionary biology, diet, and environmental conditions.

**A Broader Perspective**

Viewing metabolism through an evolutionary lens can help place modern metabolic disorders within a larger biological context.

Rather than representing entirely new diseases, many metabolic conditions may reflect the interaction between ancient physiological mechanisms and rapidly changing environments.

Examining both the evolutionary origins of metabolic pathways and the modern conditions that influence them can provide valuable insight into the biology of metabolic disease.

**Related Topics**

Readers interested in exploring these ideas further may also consult:

**• Fructose Metabolism**

**• Uric Acid and Metabolism**

**• De Novo Lipogenesis**

**• The Western Diet and the Metabolic Environment**

These pages examine the biochemical and environmental factors that interact with evolutionary metabolic pathways.
### Metabolic Dysfunction–Associated Steatotic Liver Disease (MASLD) Diagnosis
URL: https://www.internets.com/clinical-resources-masld-dx-tests/
Last updated: 2026-04-27T03:08:20.000Z
Subsection Navigation  

[Clinical Resources](https://www.internets.com/clinical-resources/) • [What is a Lipid Panel?](https://www.internets.com/clinical-resources-lipid-panel/) • [What is a Liver Panel?](https://www.internets.com/clinical-resources-liver-panel/) • [FIB-4](https://www.internets.com/cliinical-resources-fib-4/) • [TyG Index](https://www.internets.com/clinical-resources-tyg-index/) • [Fasting Glucose](https://www.internets.com/clinical-resources-fasting-glucose/) • [HbA1c](https://www.internets.com/clinical-resources-hba1c/) • [CRP and ESR](https://www.internets.com/clinical-resources-fasting-crp-esr/) • [What is a CBC?](https://www.internets.com/clinical-resources-fasting-cbc/) • [Criteria for Metabolic Syndrome](https://www.internets.com/metabolic-disease-metabolic-syndrome-definition/) • [Metabolic Screening](https://www.internets.com/clinical-resources-metabolic-screening/) • [Fatty Liver Screening](https://www.internets.com/clinical-resources-masld-dx-tests/) • [Drugs to Reverse Metabolic Syndrome](https://www.internets.com/clinical-resources-reversal-with-drugs-md/) • [School Nutrition Projects](https://www.internets.com/clinical-resources-school-nutrition-projects-who-guidelines/) • [Taro and Ube Bread on Saipan](https://www.internets.com/clinical-resources-ancestral-breads-on-saipan/) 

## MASLD Screening and Diagnosis

### **Introduction**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-05-at-11.26.41---AM.png)

Metabolic dysfunction–associated steatotic liver disease (MASLD) is one of the most common liver disorders worldwide. The condition occurs when fat accumulates within liver cells in individuals with metabolic risk factors such as obesity, insulin resistance, type 2 diabetes, or dyslipidemia.

Because MASLD often develops silently and produces few early symptoms, it frequently goes undetected until routine imaging or laboratory testing reveals evidence of liver steatosis.

Early identification of MASLD is important because the condition is closely associated with metabolic syndrome, cardiovascular disease, and progression to more advanced liver injury in some individuals.

For this reason, clinicians increasingly view MASLD not only as a liver disorder but also as a marker of systemic metabolic dysfunction.

## **What Is Hepatic Steatosis?**

The defining feature of MASLD is hepatic steatosis, or the accumulation of triglycerides within liver cells.

Small amounts of fat are normally present in the liver as part of regular metabolic activity. However, when lipid accumulation exceeds normal levels—typically defined as fat involving more than approximately five percent of liver tissue—hepatic steatosis is considered present.

This accumulation reflects an imbalance between lipid production, lipid oxidation, and lipid export from the liver.

## **Metabolic Risk Factors**

MASLD usually occurs in the presence of underlying metabolic risk factors. These commonly include:

• obesity or excess body weight

• visceral adiposity

• insulin resistance or type 2 diabetes

• elevated triglycerides

• reduced HDL cholesterol

• hypertension

Because these conditions often appear together, MASLD is frequently considered part of the broader spectrum of metabolic syndrome.

## **Why Screening Matters**

MASLD is often discovered incidentally because most individuals experience few symptoms during early stages of the disease.

However, identifying the condition can provide valuable insight into metabolic health. Liver fat accumulation often reflects broader disturbances in energy metabolism and insulin signaling.

In addition, a subset of individuals with MASLD may progress to more advanced stages of liver injury over time.

Early recognition allows clinicians to address the metabolic factors contributing to the disease before complications develop.

## **Initial Clinical Evaluation**

Evaluation for MASLD typically begins with a clinical assessment of metabolic risk factors.

Clinicians often review:

• body weight and waist circumference

• history of diabetes or insulin resistance

• blood lipid levels

• blood pressure

• lifestyle and dietary patterns

Routine laboratory testing may include measurements of liver enzymes such as alanine aminotransferase (ALT) and aspartate aminotransferase (AST). Although these markers can provide useful information, they may remain normal even when liver fat is present.

For this reason, normal liver enzymes do not exclude MASLD.

## **Imaging Techniques**

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/04/Screenshot-2026-04-13-at-8.54.32---AM.png)

Imaging studies are commonly used to detect liver fat.

Several imaging modalities may be employed:

• ultrasound, which can identify moderate or severe steatosis

• computed tomography (CT) scans, which can estimate liver fat content

• magnetic resonance imaging (MRI), which provides more precise quantification of hepatic fat

Among these methods, ultrasound is often used as an initial screening tool because it is widely available and relatively inexpensive.

## **Assessing Liver Fibrosis**

Although many individuals with MASLD have relatively stable liver disease, some may develop progressive fibrosis.

Fibrosis refers to the formation of scar tissue within the liver. Over time, advanced fibrosis can progress to cirrhosis and impaired liver function.

To evaluate fibrosis risk, clinicians may use non-invasive scoring systems such as:

• FIB-4 index

• NAFLD fibrosis score

• imaging techniques such as transient elastography

These methods help identify individuals who may benefit from further specialist evaluation.

## **Cardiometabolic Risk**

An important aspect of MASLD is its strong association with cardiovascular disease.

Many individuals with fatty liver disease also have metabolic abnormalities that increase the risk of coronary artery disease and other vascular complications.

In fact, cardiovascular disease is often the leading cause of mortality among individuals with MASLD.

For this reason, evaluation of liver fat should be accompanied by assessment of broader cardiometabolic risk factors.

## **Management Principles**

Management of MASLD focuses primarily on addressing the underlying metabolic disturbances.

Strategies commonly include:

• weight reduction when appropriate

• improved dietary patterns

• increased physical activity

• management of diabetes and dyslipidemia

• reduction of visceral adiposity

These interventions can improve metabolic health and may reduce liver fat accumulation.

## **Related Topics**

Readers interested in the metabolic processes associated with MASLD may also explore:

**• Fatty Liver Disease (MASLD)**

**• Insulin Resistance**

**• De Novo Lipogenesis**

**• Metabolic Syndrome**

These pages examine the biological mechanisms contributing to hepatic fat accumulation.
## Posts
### Locally grown yams, taro and sweet potatoes reach Saipan school menus
URL: https://www.internets.com/locally-grown-yams-taro-and-sweet-potatoes-reach-saipan-school-menus/
Last updated: 2026-10-09T00:45:45.000Z
**A pilot connecting local farmers with five public schools offers a practical way to bring island food traditions into school meals and support local agricultural markets.**

Internets welcomes a collaborative initiative bringing locally grown yams, taro and sweet potatoes into public school cafeterias on Saipan.

According to an [October 8, 2026 report from NMI News Service](https://www.nminewsservice.com/news/local/nmc-crees-local-starches-pilot-public-schools/?ref=internets.com), the local starch pilot began in March 2026\. It links farmers, school nutrition staff and food service vendors to make these crops part of students’ meals.

## A partnership from farm to cafeteria

The initiative brings together Northern Marianas College’s Cooperative Research, Extension, and Education Services (NMC-CREES), the Department of Land and Natural Resources Division of Agriculture, the Kagman Agricultural Farms and Producers Association (KAFPA), and the Public School System Child Nutrition Program.

The five participating schools are:

- Marianas High School
- Saipan Southern High School
- Hopwood Middle School
- Tanapag Middle School
- Chacha Ocean View Middle School

KAFPA producers harvest and deliver the crops to participating school food service vendors, who incorporate them into meals. Reported examples include local yam in beef and pechay soup and seasoned mashed sweet potatoes.

## Making local purchasing practical

A dependable market matters to farmers. A dependable supply matters to schools. This pilot creates a connection between the two, giving local producers access to institutional buyers while bringing locally grown foods into cafeterias.

Preparing root crops at this scale also requires equipment. The report describes an industrial produce peeler installed at Garapan Public Market on June 1, available without charge for use by farmers, ranchers and commercial food vendors.

That shared resource addresses a practical part of the supply chain: preparing larger quantities of produce for use in meals.

## Food traditions belong in the conversation

School meals can introduce students to crops grown in their own community and create opportunities to learn about farming, cooking and local food traditions.

The pilot’s cultural and agricultural value deserves recognition. Its nutritional and health outcomes, however, should be evaluated rather than assumed. Local origin alone does not determine whether a meal is balanced; preparation, portion size and the other foods served also matter.

The news report describes the program’s implementation, but does not establish measured changes in students’ health.

## Building on the pilot

As the initiative develops, useful measures of progress would include student acceptance, purchasing consistency, costs, food waste and farmers’ ability to meet demand.

Internets congratulates the farmers, nutrition staff, partner organizations and food service teams making this work possible. Bringing locally grown food into school meals is a concrete investment in the relationship between our children, our farms and our community.

**Source:** [NMI News Service, “Local yams, taro and sweet potatoes land on public school menus,” October 8, 2026.](https://www.nminewsservice.com/news/local/nmc-crees-local-starches-pilot-public-schools/?ref=internets.com)
### May 22, 2026: Grand Rounds
URL: https://www.internets.com/may-22-2026-grand-rounds/
Last updated: 2026-10-05T22:31:33.000Z
Watch the Grand Rounds recording on YouTube: h[ttps://www.youtube.com/watch?v=SYyal0Hcfsg](https://www.youtube.com/watch?v=SYyal0Hcfsg&ref=internets.com)

## [Dr. Gregor's Grand Rounds Video](https://sccgov-org.zoom.us/rec/play/iP2Ft75rO4WLHCDAvP411Qa5ZXlUcT8wmCxcC2nVaVxym4JAUcR%5Fc0efAxGBkHqgd4-OuiFz09GwregF.gJIeUorxXzkaLLPu?accessLevel=meeting&canPlayFromShare=true&from=share%5Frecording%5Fdetail&startTime=1779458319000&oldStyle=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fsccgov-org.zoom.us%2Frec%2Fshare%2F2qnkkRb6jM-aTYTCEXDASyBjWqsgIUieOvqU6nApuPfsUPfzNRTI8M5tJ2WytFSn.PK5u7kVilQcEn4uZ%3FstartTime%3D1779458319000&ref=internets-press.ghost.io)

![upload in progress, 0](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/06/Screenshot-2026-06-06-at-11.59.05---AM.png)

Presented to Santa Clara Valley Medical Center Faculty, May 22, 2026

## The Modern Metabolic Pandemic: How DNA, Diet and Destiny Collide

### The Core Problem: A Global Metabolic Collapse

  
Across continents, the same pattern is emerging: obesity, fatty liver disease, type 2 diabetes, hypertension, chronic kidney disease, and cardiovascular disease. These are not separate epidemics. They are one metabolic disorder expressing itself through multiple organs. The unifying mechanism is metabolic overload — a mismatch between human biology and the modern food environment.

### The Central Mechanism: Fructose Overload

Fructose is the biochemical accelerant of the modern metabolic crisis. It is metabolized almost entirely in the liver. It generates uric acid, fat, and oxidative stress. It suppresses ATP, triggering hunger and fat storage. It overwhelms mitochondria. It drives hepatic insulin resistance, the root of metabolic syndrome. This is not a calorie problem. It is a biochemical problem.

### The Hidden Accelerator: Genetic Vulnerability

  
Genes load the gun. The modern diet pulls the trigger. Populations with thrifty genotypes, uricase pathway mutations, ancestral famine exposure, rapid dietary modernization, or migration from low‑sugar to high‑sugar environments experience catastrophic metabolic deterioration when exposed to Westernized diets. This explains the disproportionate burden of metabolic disease in Pacific Islanders, Indigenous peoples, South Asians, Latin American populations, and African diaspora communities. Destiny is not fixed — but risk is inherited.

### The Perfect Storm: Food Systems vs. Human Biology  
  
Modern food systems are engineered for hyper‑palatability, ultra‑processing, high fructose content, low cost, and addictive reward pathways. This creates a biological mismatch between ancient genes and modern diets. The result is predictable: a global metabolic pandemic.

### The Clinical Cascade: From Liver to Lifespan  
  
Fructose overload triggers a multi‑organ cascade.  
Liver: de novo lipogenesis, NAFLD to NASH, hepatic insulin resistance.  
Pancreas: hyperinsulinemia, beta‑cell stress.  
Kidneys: uric acid–mediated injury, hypertension.  
Vasculature: endothelial dysfunction, atherosclerosis.  
Brain: appetite dysregulation, reward pathway hijacking.  
Metabolic disease is not a willpower issue. It is a systemic biochemical disorder.

### The Clinical Message: Diet Must Match DNA  
  
Personalized nutrition is essential, not optional. Patients need diets aligned with genetic ancestry, metabolic phenotype, uric acid sensitivity, mitochondrial resilience, insulin response, and liver fat burden. This is the future of preventive medicine.

![upload in progress, 0](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/06/Screenshot-2026-06-06-at-12.02.36---PM.png)

This Grand Rounds summary distills decades of clinical observation, biochemical analysis, and global public health insight into a framework that empowers individuals and communities to reclaim metabolic health.

**Comments from Dr Carlos Monteiro**: "I just watched, wonderful.", Carlos Carlos A. Monteiro MD, PhD Emeritus Professor, School of Public Health,University of Sao Paulo

**Comments from Dr Richard J Johnson**: "Hi. I just watched your talk- bravo! I am glad you realize how important fructose and uric acid are. I have hope that one day we can replace the uricase gene in humans. Congratulations again on all of your work and effort" 

Comments from Dr Dean Winslow: "Great talk, Peter! " Dean **Dean L. Winslow, MD, MACP, FRCP(Lon), FAAP, FIDSA, FPIDS,** Professor of Medicine, Division of Infectious Diseases and Geographic Medicine, Stanford University School of Medicine

---

397 words[](https://ghost.org/help/using-the-editor/?ref=internets.com)1
### Rotarians confront Diabetes
URL: https://www.internets.com/rotarians-confront-diabetes/
Last updated: 2026-10-12T06:23:57.000Z
![upload in progress, 0](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/06/Screenshot-2026-06-14-at-6.01.20---AM.png)

![](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/06/Screenshot-2026-06-14-at-6.25.21---AM-1.png)

****Increased demand for local heritage food increases local production of heritage crops.**

On Saipan, for the past 2 years, people eating taro and ube and breadfruit instead of sodas, white rice and modern breads, are losing weight and their biomarkers for gout and diabetes are improving. The local micro-economics effect is increased demand for local produce of the heritage crops of these islands. This is the proof of sustainability which can be applied by similar Rotary "[good food of our ancestors](https://www.internets.com/food-ancestral-foods/)" local initiatives, anywhere in the World.

Our latest effort was included in a Global Grant health and nutrition mission in Micronesia. A return to the heritage diets of ancestors is being tried with good initial success. Our model from the medical literature is the success of Dr. Godfrey Temba and his researchers in Tanzania as in the graphic further down in this page.

On May 22, 2026, [PP Dr Peter Gregor explained in a Medical Grand Rounds](https://sccgov-org.zoom.us/rec/play/iP2Ft75rO4WLHCDAvP411Qa5ZXlUcT8wmCxcC2nVaVxym4JAUcR%5Fc0efAxGBkHqgd4-OuiFz09GwregF.gJIeUorxXzkaLLPu?accessLevel=meeting&canPlayFromShare=true&from=share%5Frecording%5Fdetail&startTime=1779458319000&oldStyle=true&componentName=rec-play&originRequestUrl=https%3A%2F%2Fsccgov-org.zoom.us%2Frec%2Fshare%2F2qnkkRb6jM-aTYTCEXDASyBjWqsgIUieOvqU6nApuPfsUPfzNRTI8M5tJ2WytFSn.PK5u7kVilQcEn4uZ%3FstartTime%3D1779458319000&ref=internets-press.ghost.io), the metabolic syndrome and what Rotary has been doing to address this in the Western Pacific. 

December 15, 2025, Marianas Variety Newspaper covered PP [Dr. Peter Gregor's speech to the Rotary Club of Saipan](https://marianaspress.com/news/article/cardiologist-urges-return-to-ancestral-foods?ref=internets-press.ghost.io) urging a return to ancestral foods.

This website internets.com explains how all ethnicities of humans have [adapted](https://www.internets.com/food-evolution-and-diet/) to the foods available in the original environments of our ancestors. Returning to the food that kept our ancestor healthy is the most effective and economical way to reverse the diseases caused by modern food.

![upload in progress, 0](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/06/Screenshot-2026-06-14-at-9.52.29---AM.png)

The 21st Century most convenient form of heritage food is breads and other readily available food for a busy modern lifestyle. The opportunity for Rotarians all over the world is to subsidize the cost of ancient breads to match the price of modern sugar-laden breads. The difference of one or two dollars subsidy to bakeries all over the world can prevent and reverse the weight gain and biomarkers of obesity and diabetes.

That means rye [breads](https://www.internets.com/food-bread/) for Northern Europe, yam breads for Africa, taro and ube breads for the Pacific, basmati [rice](https://www.internets.com/food-rice//) for India and Asia. 

The world is facing a food induced epidemic of disease. At every local and District level, Rotarians can take this Pacific Islands model and show governments and business that returning to heritage foods can create increased demand for locally grown foods and result in increased economic activity in our communities. 

![upload in progress, 0](https://storage.ghost.io/c/3c/f7/3cf7756e-dc79-4496-a5e1-1ce466b7a418/content/images/2026/06/Screenshot-2026-06-14-at-10.09.23---AM.png)

PP Dr. Peter Gregor is available for a zoom presentation to any Rotary Club about returning to ancestral foods and how Rotarians all over the world can start this process as local sustainable micro-economic projects. Contact email is pgregor@internets.com.

436 words[](https://ghost.org/help/using-the-editor/?ref=internets.com)0